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The proper functioning of the cell depends on preserving the cellular genome. In yeast cells, a limited
number of genes are located on mitochondrial DNA. Although the mechanisms underlying nuclear
genome maintenance are well understood, much less is known about the mechanisms that ensure
mitochondrial genome stability. Mitochondria inﬂuence the stability of the nuclear genome and vice
versa. Little is known about the two-way communication and mutual inﬂuence of the nuclear and
mitochondrial genomes. Although the mitochondrial genome replicates independent of the nuclear
genome and is organized by a distinct set of mitochondrial nucleoid proteins, nearly all genome stability
mechanisms responsible for maintaining the nuclear genome, such as mismatch repair, base excision
repair, and double-strand break repair via homologous recombination or the nonhomologous end-
joining pathway, also act to protect mitochondrial DNA. In addition to mitochondria-speciﬁc DNA
polymerase γ, the polymerases α, η, ζ, and Rev1 have been found in this organelle. A nuclear genome
instability phenotype results from a failure of various mitochondrial functions, such as an electron
transport chain activity breakdown leading to a decrease in ATP production, a reduction in the
mitochondrial membrane potential (ΔΨ), and a block in nucleotide and amino acid biosynthesis. The
loss of ΔΨ inhibits the production of iron–sulfur prosthetic groups, which impairs the assembly of Fe–S
proteins, including those that mediate DNA transactions; disturbs iron homeostasis; leads to oxidative
stress; and perturbs wobble tRNA modiﬁcation and ribosome assembly, thereby affecting translation and
leading to proteotoxic stress. In this review, we present the current knowledge of the mechanisms that
govern mitochondrial genome maintenance and demonstrate ways in which the impairment of
mitochondrial function can affect nuclear genome stability.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Mitochondria are double-membrane-bound organelles that are
thought to have evolved from endosymbiotic α-proteobacteria and
that are essential for the viability of eukaryotic cells. Mitochondria
perform a variety of functions: produce bulk cellular ATP through the
energy conversion reactions of oxidative phosphorylation and the
tricarboxylic acid cycle; maintain and express the residual mitochon-
drial genome that is required for oxidative phosphorylation; perform
important steps of heme biosynthesis, amino acid biosynthesis,
nucleotide biosynthesis, the urea cycle, and fatty acid metabolism;
and participate in apoptosis and reactive oxygen species production.
Mitoproteomics studies have indicated that there are ca. 1000
mitochondrial proteins in cells of the yeast Saccharomyces cerevisiae
[1,2] and ca. 1500 proteins in human mitochondria [3]. Only a small
fraction of these proteins is encoded by mitochondrial genomes, and
this group primarily includes proteins involved in oxidative phos-
phorylation and ATP synthesis (8 proteins in yeast mitochondria and
13 proteins in human mitochondria, because yeast mitochondria lack
subunits of the respiratory chain complex I that are present in human
mitochondria), as well as rRNA and tRNA genes that are required for
mitochondrial gene expression. Consequently, the vast majority of
mitochondrial proteins are encoded by the nuclear genome, synthe-
sized on cytosolic ribosomes and imported into the mitochondria
[4,5]. None of the mitochondrial functions listed above are essential
for the viability of S. cerevisiae cells, yet protein import into mitochon-
dria is essential [4], highlighting the importance of this cellular
compartment. One of the recently recognized essential roles played
by mitochondria is the generation and maturation of Fe–S prosthetic
groups (iron–sulfur clusters, ISCs)1 for both mitochondrial and extra-
mitochondrial Fe–S proteins [6,7]. ISCs are crucial for facilitating redox
enzyme activities and are required for enzymes engaged in DNA
replication; they are also components of various protein complexes,
including cytosolic ribosomes [8–10]. ISC synthesis is important not
only for Fe–S protein assembly, but also for metal ion homeostasis,
the proper cellular stress response, and the execution of apoptosis.
Not surprisingly, a defect in this particular mitochondrial functionwas
found to be responsible for the mitochondria-dependent nuclear
mutator phenotype [11]. Mitochondrial DNA-encoded genetic infor-
mation, although minuscule compared to that of the nuclear genome,
is required for the proper functioning of mitochondria and subse-
quently for nuclear genome maintenance [12]; thus, eukaryotic cells
have retained mitochondrial DNA (mtDNA) throughout evolution, and
special mechanisms have evolved to preserve mtDNA.
Maintenance of the mitochondrial genome
How is the ability to maintain stable mitochondrial DNA determined
in S. cerevisiae cells?
Before describing the mtDNAmaintenance pathways that function
in yeast cells, we will introduce a few terms that are speciﬁc to
S. cerevisiae mitochondrial genetics and describe the nonrespiratory
reporter gene that was engineered into the yeast mitochondrial
genome and shown to be a useful tool for assaying mtDNA stability
in this organism. Because S. cerevisiae cells remain viable upon the
loss of functional mtDNA, known as the rhoþ mitochondrial genome,
the so-called cytoplasmic petitemutants, i.e., nonrespiring clones that
form minute colonies on standard glucose-limited medium, can be
isolated easily (reviewed in [13]). These mutants arise from either
extensive deletions of mtDNA followed by reampliﬁcation of the
remaining fragment (rho genomes/mutants) or a complete loss of
mtDNA (rho0 mutants). Therefore, at least three rho genotypes are
possible: rhoþ (wild-type), rho (partial deletion of the mitochondrial
genome), and rho0 (complete loss of mtDNA).
Although rho and rho0 petites are phenotypically identical, they
probably originate from fundamentally different mechanisms.
Petites with no mtDNA are often produced by a failure to transmit
mtDNA to the progeny, whereas rho petitesmost likely result from
recombination events that form partially deleted and rearranged
mtDNA molecules (reviewed in [13,14]). The petite mutations are
markedly pleiotropic because the mutants are unable to perform
mitochondrial protein synthesis (essential components of the
mitochondrial translation apparatus are encoded by mtDNA, see
Introduction). This feature is mainly the consequence of the nuclear
transcriptional reprogramming that occurs in yeast cells in response
to a rho/rho0 mutation (reviewed in [15]). Spontaneous cytoplas-
mic petite mutants are quite common; in saturated cultures on
glucose-containing medium, the fraction of petite cells may reach
1–2% [14,16,17]. However, the frequency of spontaneous and
induced mitochondrial point mutations is several orders of magni-
tude lower than the incidence of petite mutants [18–21]. This
dramatic difference clearly indicates that the mechanisms under-
lying the generation of these two types of alterations in mtDNA,
cytoplasmic petite and point mutations, are divergent.
The levels of mitochondrial point mutagenesis can be estimated
from the frequency of mutants that are resistant to antibiotics that
target various mitochondrial processes. These antibiotics include the
following: (1) erythromycin and chloramphenicol, which inhibit
mitochondrial protein synthesis; (2) oligomycin, which inhibits mito-
chondrial ATP synthase; and (3) antimycin, which blocks electron ﬂow
through the respiratory chain at complex III [13,22]. Erythromycin
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resistance is acquired through mutations at several positions in the
mitochondrial 21S rRNA gene [23]. Oligomycin resistance is acquired
through speciﬁc point mutations in the mitochondrial OLI1 and OLI2
genes, which encode subunits 9 and 6, respectively, of the mitochon-
drial ATPase complex [24,25]. Resistance to antimycin Awas attributed
to point mutations in the mitochondrial gene COB, which codes for
cytochrome b [26]. However, certain mutations conferring resistance
to all of these antibiotics are localized to the nuclear genome, but these
nuclear mutations are relatively rare in the case of erythromycin
resistance. Each case of antibiotic-resistance mutagenesis that can be
attributed to mitochondrial genome instability needs to be reevaluated
to exclude the presence of nuclear mutations that present identical
phenotypes. In questionable cases, a genetic test verifying the non-
Mendelian vs Mendelian inheritance of the resistance phenotype
should be performed as proposed by Barufﬁni et al. [17]. This step is
particularly important when testing mutants that are deﬁcient in DNA
repair factors that have both nuclear and mitochondrial versions. As
discussed below, numerous proteins engaged in DNA transactions are
shared by both the nucleus and the mitochondria.
To complete the overview of S. cerevisiae mtDNA mutants, point
mutations in the mtDNA, the so-called mit rhoþ mutations, can be
isolated, and these mutations cause respiratory deﬁciency through
the impairment of only one gene (or a few genes) within the
components of the respiratory chain without disrupting the integrity
of the rhoþ genome [27]. These mutants exhibit proﬁcient mitochon-
drial gene expression. Spontaneous mit mutations are usually
reversible, in contrast to rho and rho0 mutations, and are as rare
as other mitochondrial point mutations (see the discussion above).
Mitochondrial mutants of this type are mentioned here because a
special mit rhoþ strain was constructed with a mitochondrial
nonrespiratory reporter gene ARG8m [28]. In this reporter gene, the
sequence of ARG8 was recoded to ﬁt the yeast mitochondrial genetic
code for coding the same protein as the wild-type nuclear gene ARG8,
synthesized, and inserted into yeast mtDNA in place of the COX3 gene.
The ARG8 gene encodes acetylornithine aminotransferase, a mito-
chondrial matrix enzyme that catalyzes the fourth step in arginine
biosynthesis. The mitochondrial cox3: ARG8m gene fully complemen-
ted the arginine auxotrophy of a strain lacking nuclear ARG8. As
expected, expression of the gene was dependent on the mitochon-
drial translational activator complex speciﬁc to COX3 mitochondrial
mRNA. This reporter gene was used in many studies of mitochondrial
gene expression at many locations in the mitochondrial genome and
with various modiﬁcations, helping to decipher the intricacies of the
gene-speciﬁc posttranscriptional mechanisms that control the expres-
sion of mitochondrial genes in S. cerevisiae (the limited space and
scope of this review do not allow citing all of the literature on the
subject, but it is reviewed in Lipinski et al. [29]).
Another signiﬁcant modiﬁcation of cox3: ARG8m, published in
2000, aimed to measure the stability of repetitive (microsatellite)
sequences in mtDNA [30]. The authors inserted a series of out-of-
frame poly(AT) or poly(GT) tracts into the cox3: ARG8m gene to
screen for repeat rearrangement events that restored reporter
expression. Using this system, the authors showed that poly(AT)
tracts, which often occur as natural mitochondrial microsatellites,
are much more stable than are poly(GT) tracts and that frameshift
mutations usually involve deletions rather than additions of repeat
units. The difference in stability between poly(AT) and poly(GT)
tracts may not depend as much on their sequences as on the
ability of the former to form hairpin secondary structures if
present in single-stranded DNA (ssDNA). In contrast, in the nuclear
genome, poly(GT) and poly(AT) tracts had similar stabilities, and
changes to these sequences usually involved additions rather than
deletions. These results suggest that the mechanisms mediating
the stability of microsatellite sequences in mtDNA differ from the
corresponding mechanisms that function in the nucleus. Another
interesting difference between the stability of mitochondrial and
nuclear microsatellites is a signiﬁcantly increased stability (by
100-fold) of mitochondrial microsatellite tracts in diploid cells
compared with the stability of the corresponding tracts in haploid
cells [30,31], whereas no difference between diploid and haploid
cells was observed in the frequency of frameshift mutations
generated within nuclear microsatellite sequences. The research-
ers showed that the increased stability of mtDNA in diploid cells
was due to ploidy alone, rather than mating type-speciﬁc gene
expression, but they did not ﬁnd the exact mechanism to account
for this ploidy effect. Later, the group of E. Sia improved their
reporter strains for assaying frameshift mutations by constructing
a respiratory-competent strain with poly(GT) tracts that inter-
rupted the ARG8m inserted into the mtDNA in a manner that
allowed gene expression of the whole mitochondrial genome [32].
Moreover, the same group made signiﬁcant progress in the study
of mtDNA repair pathways by constructing a strain carrying
mtDNA with the COX2 gene interrupted by a functional ARG8m
gene ﬂanked by 96-bp direct repeats. Using this reporter strain,
the authors measured the rate at which direct repeat-mediated
deletions (DRM(D)) arise in the mitochondrial genome of
S. cerevisiae [33]. The results showed that the DRM(D) reporter
can be destabilized by at least two independent pathways. One
predominant pathway generates only deletions in noncrossover
arrangement (which may be due to polymerase slippage, template
switch, or a single-strand annealing event), and the other pathway,
which operates at a much lower efﬁciency, generates reciprocal
products in addition to deletions. Consequently, the minor path-
way displays the hallmarks of a recombination pathway involving
a structure-speciﬁc endonuclease that resolves Holliday junctions.
However, an important piece of information about the other,
predominant DRM(D)-destabilizing pathway came from experi-
ments with the DRM(D) reporter in a strain carrying the mip1-
D347A mutation, which causes a strong defect in the 30-50
exonuclease activity of mitochondrial polymerase [18]. The dele-
tion rate in the exonuclease mutant was 4-fold lower than that in
MIP1 strains [33], and the authors speculated that most of the
polymerase slippage events that lead to direct repeat deletions in
mtDNA may occur during proofreading. Interestingly, the set of
DRM(D) reporters constructed by E. Sia's lab with direct repeats of
varying lengths ranging from 33 to 96bp displayed the inverse
relationship between the repeat length and the stability of the
repeat. The shortest repeat was the most stable, and the longest
was the least. The DRM(D) reporter with even a shorter repeat of
21bp displayed 1000-fold higher stability that the most stable
reporter among those with longer repeats. As the authors have
pointed out, the results show that the minimal efﬁcient processing
segment (MEPS) for the mitochondrial DRM(D) rearrangement
pathway falls between 33 and 21bp. Apparently, for repeats of
shorter length than the mitochondrial MEPS other mechanisms
than those mediating DRM(D) rearrangements start to predomi-
nate, thereby promoting repeat stability. To conﬁrm the notion
about the different mode of repeat stability regulation for direct
repeats shorter than the mitochondrial MEPS, Stumpf and Cope-
land [34] showed that in the case of the shortest (21-bp direct
repeat) and the most stable DRM(D) reporter the expression of an
exonuclease-deﬁcient allele of MIP1 destabilized the repeat
sequence, opposite to the above-mentioned suppression effect of
mip1-D347A on the stability of the 96-bp reporter. Therefore,
studying the DRM(D) reporters will bring a better understanding
of the complicated mitochondrial pathways that counteract gen-
ome rearrangements during mtDNA replication.
As mentioned above, the minor DRM(D)-destabilizing path-
way appears to be associated with crossover-linked homologous
recombination (HR). The primary role of HR, in both this system
and all others, is to repair two types of harmful lesions, double-
strand breaks (DSBs) and single-strand breaks (SSBs), that arise in
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DNA after replication fork collapse, either from the processing of
spontaneous damage or from exposure to DNA-damaging agents
[35]. As in the nucleus, HR in mitochondria may take place to
support mtDNA stability or to destabilize the mitochondrial
genome depending on the circumstances. A simple distinction
between these two effects of HR on genome integrity is asso-
ciated with the choice of partner sequences selected for homo-
logous pairing: allelic or nonallelic sequences. HR between allelic
sequences is likely to result in an error-free repair event and
plays a stabilizing role in the mitochondrial genome integrity. In
contrast, HR between nonallelic sequences, e.g., between the
repeated sequences in the DRM(D) reporter system, is likely to
produce genomic rearrangements and, as a result, this recombi-
nation event may destabilize the mtDNA. In mitochondria, owing
to the known properties of yeast mitochondrial genomes (high
copy number, presence of repetitive sequences), there are many
occasions for both allelic and nonallelic HR events. Because the
DRM(D) reporter system detects nonallelic recombination events,
an experimental system was proposed for testing allelic HR in
yeast mitochondria based on heteroallelic recombination in
crosses between strains carrying different defective alleles of
the original cox3Δ: ARG8m reporter [36]. The results obtained
with this experimental system are described in later sections.
Mitochondrial nucleoid proteins in S. cerevisiae
Mitochondrial DNA is packaged in compact, though dynamic,
nucleoprotein complexes known as nucleoids [37,38]. Yeast cells
contain up to 40 nucleoids, whereas even 10 to 20 times as many
nucleoids can be found in human cells. The number of molecules
of mtDNA in one yeast nucleoid varies depending on the growth
conditions; only 1 or 2 molecules of mtDNA are found in the
nucleoids of aerobically growing cells, and 20 mtDNA molecules
can be found in the nucleoids of cells grown under anaerobiosis.
The protein components of mitochondrial nucleoids from various
organisms have been identiﬁed. These proteins can be divided into
four groups: (1) proteins with known functions in DNA transac-
tions and packaging; (2) proteins engaged in protein quality
control, i.e., chaperonins and proteases; (3) various metabolic
enzymes (some of them are characterized as bifunctional, see
below); and (4) cytoskeletal components (in nucleoids from higher
eukaryotes). The nucleoid-associated metabolic enzymes (group 3)
share little overlap among species, which is not surprising because
bifunctional metabolic enzymes seem to connect mtDNA main-
tenance to various metabolic or environmental signals that can be
quite divergent for organisms from different phylogenetic lineages
[38]. However, one basic mitochondrial nucleoid protein is con-
served from yeast to human cells. The main packaging protein in
nucleoids is a protein from the eukaryotic high-mobility group
family: the Abf2 protein in yeast mitochondria and the mitochon-
drial transcription factor A (TFAM) in human mitochondria.
In contrast to TFAM, no speciﬁc role for Abf2 in regulating
transcription in yeast mitochondria has been uncovered. Abf2 binds
most of the mitochondrial genome, with a minor preference for
GC-rich sequences [39]. Many lines of evidence suggest that the
abundance of Abf2 determines the degree of compaction and
the structure of nucleoids. Nevertheless, Abf2 is not required for the
maintenance of rhoþ genomes. Difﬂey and Stillman [40] showed that
abf2-null mutants lose their mtDNA when grown on a rich glucose
medium, but they can be grown on medium with nonfermentable
substrates as the sole carbon sources or with other nonrepressing
substrates [41]. Under these conditions, the expression of another
mitochondrial nucleoid protein, Aco1, is induced in yeast cells because
the Hap2–5 transcription complex, which is required for the expression
of many mitochondrial proteins that function in electron transport and
the tricarboxylic acid (TCA) cycle, becomes glucose derepressed [42].
The expression of ACO1 is also positively regulated by the transcription
factors Rtg1p and Rtg3p, which are effectors of the mitochondria-to-
nucleus retrograde (RTG) signaling pathway that responds to the level
of cellular glutamate [42]. The Aco1 protein is a bifunctional ISC protein
in yeast mitochondria that serves as both the mitochondrial enzyme in
the TCA cycle and the nucleoid protein required for the maintenance of
rhoþ mtDNA; aco1-null mutants are invariably rho0 [41,43]. The two
functions of Aco1 are fulﬁlled by separate domains of the protein; a
subset of aco1 mutants is deﬁcient in the catalytic activity of aconitase
(disrupting the ISC of the enzyme), but maintain rhoþ mtDNA [41].
Thus, the overproduction of Aco1 in the mitochondrial nucleoid can
partially replace the Abf2 protein, suggesting that Aco1 may provide
some level of mtDNA packaging or protection. However, a recent study
provided an alternative explanation for the loss of mtDNA in aco1-null
strains and showed that mtDNA loss after the deletion of ACO1 is
merely an indirect consequence of citrate overproduction by the
perturbed TCA cycle and the resulting iron-dependent oxidative stress
in mitochondria [44]. These results are described in more detail in a
later section. Nevertheless, even if Aco1 is not required for the
maintenance of mtDNA andmtDNA loss in aco1-null cells is dependent
on citrate accumulation, these insights do not contradict the earlier
ﬁndings on the bifunctional role of Aco1 in the yeast mitochondrion. In
addition to Aco1, another yeast mitochondrial nucleoid-associated
metabolic enzyme, Ilv5 (which is involved in branched-chain amino
acid biosynthesis as the acetohydroxy acid reductoisomerase), can
replace Abf2 under conditions of general amino acid control pathway
induction in cells growing without the amino acids isoleucine, leucine,
and valine [45] or in cells in which the ILV5 gene is overexpressed [46].
Furthermore, under conditions in which Aco1 replaces Abf2
(i.e., in abf2Δ cells growing on nonrepressing carbon sources),
mitochondrial nucleoids are less protected, and their DNA is more
sensitive to nuclease attack [47] and oxidative damage [19]. Using
the ARG8m reporters described above, Sia et al. [48] showed that
abf2Δ strains growing under conditions that maintain rhoþ
mtDNA exhibit the following: (1) increased instability of micro-
satellite sequences in mtDNA, indicating elevated susceptibility to
polymerase slippage during the replication of microsatellite
repeats, and (2) increased instability of direct repeats (the DRM
(D) reporter) in mtDNA, suggesting a defect in the mechanisms
that mediate nonallelic recombination surveillance in mitochon-
dria. In fact, the two mutant phenotypes of abf2Δ strains are
consistent with one another because the critical destabilizing
pathway appears to involve polymerase slippage events in both
reporter systems [30,33], as discussed above. Surprisingly, abf2Δ
deletion mutants did not show any change in the number of point
mutations in the mtDNA relative to the reference strain [48]. Thus,
nucleoid-associated Abf2 may participate in a mechanism that
prevents undesirable polymerase slippage events. Certainly, this
role of Abf2 is critical for the basic function of the protein in the
maintenance of rhoþ mtDNA. The results discussed above also
imply that, to a certain extent, both Aco1 and Ilv5 can replace Abf2
in the nucleoid function associated with preventing rearrange-
ments in mtDNA.
Major mtDNA-packaging proteins, such as Abf2, may participate
in diverse mtDNA transactions. We have presented evidence of the
role of nucleoid proteins in the prevention of mitochondrial genome
rearrangements, but strong evidence indicates that Abf2 is also a
positive factor in HR. MacAlpine et al. [49] showed by two-
dimensional (2D) gel electrophoresis that Abf2 promotes or stabi-
lizes Holliday recombination junction intermediates in rhoþ mtDNA
in vivo, but does not inﬂuence the high levels of recombination
intermediates found in the mtDNA of rho petitemutants. Therefore,
Abf2 is a positive factor for certain recombination processes in
mitochondria but is not involved in other complex recombination
pathways in yeast mitochondria. Strangely, support for this function
of Abf2 came from unexpected sources: studies on mtDNA
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replication in mammalian cells. In transgenic mice overexpressing
human TFAM, a dramatic increase in Holliday junctions and complex
mtDNA forms was detected [50]. Not surprisingly, human TFAM
expressed in yeast cells was shown to rescue the loss-of-mtDNA
phenotype of abf2Δ cells [51], suggesting evolutionary conservation
of the functions mediated by these mtDNA-packaging proteins in
maintaining the mitochondrial genome.
Replication of yeast mitochondrial DNA
The mitochondrial genome in budding yeast cells is replicated by a
dedicated mitochondrial polymerase, Mip1. Strains lacking the MIP1
gene are rho0 [43,52], indicating that Mip1 is the major, if not unique
(see below), replicative DNA polymerase in the mitochondria of this
species. The yeast polymerase γ functions as a single-subunit enzyme
that forms only the catalytic subunit of Mip1 [53,54]; this polymerase
differs from the mitochondrial polymerases of other eukaryotes,
which are usually hetero-oligomeric [55]. In addition, an in vitro
study showed that Mip1 is a highly processive DNA polymerase with
strong strand-displacement activity [54]. As discussed below, this
polymerase activity is required in certain DNA repair pathways and in
the Okazaki fragment processing pathway in the nucleus. The
catalytic subunit of polymerase γ is phylogenetically related to the
prokaryotic PolA family, and its amino acid sequence has been well
conserved throughout the evolution of eukaryotic cells. The N-
terminal part of the protein contains two domains endowed with
50-dRP (50-deoxyribose phosphate) lyase and 30-50 exonuclease
proofreading activities [55]. The former activity is important for
elimination of the dRP moiety necessary for single-nucleotide gap-
ﬁlling during base excision repair (see below), whereas the latter is
crucial for ensuring the ﬁdelity of mtDNA replication by polymerase γ.
The above-mentioned mip1-D347A mutation, which causes a strong
defect in the 30-50 exonuclease activity of the mitochondrial poly-
merase, elicits a several hundredfold increase in the frequency of
spontaneous mutations, leading to erythromycin resistance and a
severalfold increase in the incidence of rho petite mutants [18].
The MIP1 gene in budding yeast has been used as a model to
study pathogenic mutations in POLG (also called POLG1; the gene
encoding the catalytic subunit of human polymerase γ) associated
with several mitochondrial diseases found in patients suffering
from aggressive Alpers syndrome to mild progressive external
ophthalmoplegia [56,57]. These studies have determined DNA
replication defects that are conferred within 30 mutations and
strongly support a model in which these mutations contribute to
the manifestation of disease. Moreover, Barufﬁni et al. [58] showed
that the increase in petite frequency in a subset of these Mip1-
deﬁcient mutants can be suppressed by an increase in the
mitochondrial dNTP pool or exposure to the antioxidant dihydro-
lipoic acid, which presumably decreases reactive oxygen species
(ROS). Mutator mice, which express an exonuclease-deﬁcient
mtDNA polymerase γ, age prematurely owing to the accumulation
of point mutations and mtDNA chromosomal breakage [59,60].
Surprisingly, impaired mitochondrial respiratory activity in these
mice does not lead to increased oxidative stress but is associated
with the activation of apoptosis and the ensuing tissue progenitor
dysfunction. This result is consistent with the notion that mito-
chondrial dysfunction not only correlates with aging but also
represents an important causative aging factor.
A very recent report examined disease-associated mutations that
affect conserved regions of the Mip1 polymerase [61]. In that study,
variousmip1 mutations were tested in heterozygous strains harbor-
ing both a mutant copy of the MIP1 gene and the wild-type copy,
and the strains were exposed to the exogenous base-alkylating
agent, methyl methanesulfonate (MMS). In this experimental setup,
mutations that disrupted Mip1 polymerase activity, but not those
that inactivated exonuclease activity, caused an increased frequency
of point mutations in mtDNA after MMS exposure. First, these
results indicate that the exposure to mutagenic compounds may
greatly increase mtDNA mutagenesis, indicating the necessity of
including environmental factors in the study of the mechanisms
responsible for maintaining mtDNA stability. Second, the results
imply that polymerase switching events occur during mtDNA
replication and that one polymerase can stall replication and be
replaced by another polymerase. In this case, stalling by a variant
Mip1 polymerase is presumed to produce ssDNA intermediates that
tend to accumulate irreparable damage during exposure to the
mutagenic agent, leading to misincorporations after the wild-type
polymerase resumes replication of the mtDNA region.
With the exception of the major replicative mitochondrial poly-
merase identity, not much is knownwith comparable certainty about
mtDNA replication in S. cerevisiae cells. Maleszka et al. [62] presented
convincing evidence that mtDNA is not predominantly circular but
rather forms heterogeneous linear tandem (concatameric) arrays of
two to seven genomic units, and only a small fraction of the mtDNA
assumes a circular form. Furthermore, because the same authors
detected circular molecules of mtDNA with either single- or double-
stranded tails (lariats) by electron microscopy, they proposed a
rolling-circle replication (RCR) mechanism as the model of yeast
mtDNA replication. This mode of replication also implies that the
synthesis of the leading and lagging strands is uncoupled in mito-
chondria. Replication of mtDNA in yeast cells appears to be initiated
by two alternative, nonexclusive mechanisms: (1) transcription-
dependent initiation that is mediated by the mitochondrial RNA
polymerase Rpo41 from three or four replication origins [63,64] and
(2) recombination-dependent replication (RDR) that is mediated, at
least partially, by the mitochondrial recombinase Mhr1 ([65,66],
reviewed in [29]). In the ﬁrst mechanism, the replication origins are
transcription sites that are recognized by Rpo41 to initiate the
synthesis of transcripts that are then processed to produce primers
for replication. Upon inactivation of the RPO41 gene, yeast cells are
not able to maintain rhoþ mitochondrial genomes, but rho gen-
omes, even those containing mostly repeated ori sequences, are still
replicated [67,68]. Because the deﬁciency of mitochondrial protein
synthesis leads to mitochondrial genome instability and the accumu-
lation of cells with mitochondria carrying rho genomes [69],
whether Rpo41 is required for the replication of rhoþ mtDNA remains
unclear. The second mechanism was proposed to explain the ﬁnding
that the major species of mtDNA in mother cells is concatamers,
whereas those in buds are circular monomers [65]. The Mhr1 protein
is required for the transmission of nascent concatameric mtDNA into
the buds. The protein was shown in vitro to catalyze a recombinase
reaction of ssDNA pairing with homologous dsDNA to form hetero-
duplex joints, which are intermediates of HR. However, Mhr1 is not
structurally related to the RecA family of recombinases, and the
pairing reaction mediated by Mhr1 is ATP-independent and topolo-
gically different from that catalyzed by RecA [70]. In the model
proposed by Ling and Shibata [65], Mhr1-mediated pairing generates
a primer for mtDNA RCR that leads to the formation of concatameric
DNA. This model was supported by several subsequent studies
reviewed by Lipinski et al. [29], the most notable of which was a
study indicating that ROS exposure regulates mtDNA copy number by
promoting Mhr1-dependent initiation of RCR at the ROS-generated
DSB ends [71]. Nevertheless, Mhr1 does not appear to be the only
mitochondrial recombinase [72]. A similar conclusion was also
proposed in a recent study on the genome-wide recombination
mapping of the mitochondrial genome in S. cerevisiae using high-
throughput sequencing [73]. In addition, the severe unconditional
phenotype of theMHR1 deletion due to the loss of rhoþ genomes [43]
is inconsistent with the mild phenotype of the mhr1-1 mutant
(temperature-dependent loss of rhoþ mtDNA). This allele encodes a
mutated Mhr1 protein, which is inactive in the pairing reaction
in vitro, in contrast to wild-type Mhr1 [65]. Therefore, Mhr1 may
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play another, not-yet-identiﬁed but indispensable, role in the main-
tenance of rhoþ mtDNA. Signiﬁcant support for the RDR mechanisms
of mtDNA replication came from a recent study utilizing two-
dimensional agarose gel electrophoresis to analyze replication inter-
mediates formed by mtDNA isolated from another yeast species,
Candida albicans [74]. The authors provided clear evidence that HR,
not transcription, predominantly initiates mtDNA replication in this
species. It is thought possible that budding yeast cells use a mixed
mode of replication initiation that is partly transcription driven and
partly recombination driven.
We have even less clear physical evidence about how lagging-
strand synthesis proceeds in yeast mitochondria. Surprisingly,
nearly the entire Okazaki fragment processing apparatus appears
to be present in yeast mitochondria, including the largest subunit
of polymerase α, Pol1, with its accessory subunit Pol12 [75].
Whether these proteins are involved in lagging-strand synthesis
or play other roles in mitochondria (see below) remains unknown.
The Pif1 helicase (with the activity of a 50-30 DNA helicase)
localizes to both the nucleus and the mitochondria [76,77]. The
Rad27 ﬂap endonuclease (the human FEN1 ortholog) is also a
dual-localization protein [78,79]. Finally, the essential Dna2 nucle-
ase/helicase presumably localizes to yeast mitochondria [80],
although its mitochondrial function, which is overshadowed by
its essential nuclear function, has not been characterized in yeast
cells. The activities of all three of these proteins have been
characterized in detail, and all steps of the Okazaki fragment
processing pathway in which they participate in the yeast nucleus
were reconstituted in vitro using puriﬁed proteins and model
substrates [81,82]. The dual localization of these three proteins is
conserved across a diverse range of eukaryotic cells, from budding
yeast to human cells [83–85], suggesting that these proteins play
one or more fundamental roles in mtDNA metabolism.
The evidence supporting the role of Dna2 in mtDNA stability is
particularly fascinating. Dna2 is an essential multitasking enzyme
with dual-polarity exo/endonuclease and 50-30 DNA helicase
activity that is involved in Okazaki fragment processing [81], as
mentioned above, and DSB repair [86]. First, owing to its enzy-
matic versatility, Dna2 may participate in mtDNA replication as a
replicative helicase together with the Pif1 and Hmi1 helicases,
which are thought to play this role in yeast mitochondria [54].
Second, Dna2 may also participate in lagging-strand synthesis in a
manner similar to the mechanism of reconstituted Okazaki frag-
ment processing. Third, Dna2 may provide the 50-strand resection
activity necessary for homologous replication, including RDR
initiation. Finally, the enzyme may play a role in DNA repair
pathways (see below). Interestingly, Dna2 contains a conserved ISC
domain that spans the nuclease active site in the N-terminal part
of the protein. Mutations that alter the cysteine residues within
the domain involved in metal coordination reduce the nuclease
activity and ATPase activity of Dna2, suggesting that the nuclease
and helicase activities are coupled [87]. A metal cluster-defective
enzyme can have substantial nuclease activity for ssDNA sub-
strates, but lacks the ability to act on other DNA conﬁgurations,
indicating that both metal-containing and metal-free enzyme
variants play distinct roles in vivo. Accordingly, Dna2 activity
may be regulated by its association with ISC, although the
prosthetic group is required for the essential function of Dna2.
The Pif1 helicase has been implicated in several mtDNA
transactions, from replication through recombination [reviewed
in 14] to repair [19,88,89]. The most signiﬁcant new ﬁnding for
Pif1 helicase is its involvement in the replication of hard-to-
replicate secondary DNA structures, particularly G-quadruplets
(G4 structures; [90,91]). G4 DNA structures are stable four-
stranded secondary structures held together by non-Watson–Crick
G–G base pairs; despite their conservation and functional signiﬁ-
cance, these structures appear to slow replication and introduce
breaks in Pif1-deﬁcient cells [92]. The Pif1 helicase, which exhibits
potent G4 structure unwinding activity in vitro, was suggested to
be the accessory replicative helicase that resolves G4 structures to
prevent fork stalling and DNA breakage during replication. This
activity of Pif1 is likely to be very important for the maintenance of
mtDNA because there is a 10-fold higher concentration of G4
motifs in AT-rich yeast mitochondrial DNA than in nuclear DNA
[90]. This conclusion is consistent with the results of the 2D gel
analysis by Cheng et al. [89], who studied mtDNA replication
intermediates in pif1-null cells, showing that in cells lacking Pif1
mtDNA breaks at speciﬁc sites even if unchallenged with genotoxic
conditions.
Other mitochondrial DNA polymerases
The set of mitochondrial polymerases in yeast cells is not
restricted merely to the replicative polymerases, polymerase γ
and polymerase α, but also includes translesion synthesis (TLS)
polymerases. TLS polymerases usually replace stalled replicative
DNA polymerases at damaged template strands to bypass a variety
of lesions [93]. Zhang et al. [94] presented the ﬁrst report to
demonstrate that DNA polymerase ζ (Rev3/Rev7) and Rev1 func-
tion in the mitochondria of S. cerevisiae in separate pathways.
Polymerase ζ is a B-family DNA polymerase that participates in
DNA translesion synthesis, which is responsible for both sponta-
neous and damage-induced mutagenesis in all eukaryotic cells
[95]. Its activity tends to generate mutations because it lacks 30-
50 exonucleolytic proofreading activity and extends mismatched
primer-template termini [96]. The REV1 gene encodes a deoxycy-
tidyl transferase that preferentially incorporates deoxycytidine
opposite an abasic site [97]. Rev1 also interacts with Rev3
in vitro, and this interaction strongly stimulates the activity of
polymerase ζ and contributes to its targeting to the replication
fork stalled at a DNA lesion [98]. Thus, the expectation was that
mutants lacking genes coding for these TLS polymerases would
exhibit a mitochondrial anti-mutator phenotype. A study by Kalifa
and Sia [99] analyzed mitochondrial genome mutagenesis in
strains with individual deletions of REV3, REV7, and REV1 using
the mitochondrial reporters described above. Although polymer-
ase ζ and Rev1 are responsible for the majority of spontaneous and
UV-induced frameshift mutations associated with mitochondrial
microsatellite sequences, mutant strains lacking polymerase ζ, but
not those lacking Rev1, showed, contrary to expectations, an
increase in spontaneous mitochondrial point mutagenesis as
measured by the frequency of erythromycin-resistant mutants. In
addition, the loss of all three proteins led to signiﬁcantly decreased
levels of UV-induced petite mutants while simultaneously increas-
ing the levels of point mutations in UV-surviving cells. Therefore,
in contrast to TLS repair in the nucleus, polymerase ζ and Rev1
appear to function in separate, largely independent pathways in
yeast mitochondria. Second, the damage tolerance pathway (or
pathways) in yeast mitochondria is more mutagenic than those of
polymerase ζ and Rev1 and is responsible for generating muta-
tions in mtDNA in the absence of TLS polymerases. In several
reported cases, mitochondrial base excision repair (BER) pathways
appear to contribute to mitochondrial mutagenesis. Whether the
increased mitochondrial mutagenesis observed to be associated
with rev3Δ, rev7Δ, and rev1Δ depends on factors that are known
to function in mitochondrial BER remains unclear.
In light of a recent report on the actual four-subunit structure of
nuclear TLS-proﬁcient polymerase ζ as an ISC-dependent complex
with Pol31 and Pol32 [100], both polymerase ζ and Rev1 may form
mitochondria-speciﬁc complexes that exhibit distinct properties
compared with those of the Rev3/Rev7- and Rev1-containing com-
plexes that function in the nucleus. Whether Pol31 and Pol32 or
Pol30/proliferating cell nuclear antigen (PCNA) are present in
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mitochondria remains a matter of debate and should be experimen-
tally veriﬁed. Mitochondrially localized Pol30 in yeast cells has been
reported previously [101], but in classical Western blot analysis of
mitochondrial proteins, anti-PCNA antibodies are used as a control for
the nucleocytosolic contamination of mitochondrial extracts (e.g.,
[102]). Consequently, there is no agreement about the presence of
Pol30 in mitochondria. Adding another twist to the story about
mitochondrial TLS polymerases, Barufﬁni et al. [103] showed that
REV3 overexpression reduced the level of petitemutants accumulating
in cultures of strains that bear a subclass of pathological mutations in
the MIP1 gene. This effect was dependent on Rev7 but not Rev1. In
addition, the overexpression of both REV3 and REV1, but not of each
individual gene, resulted in a signiﬁcant reduction in the frequency of
erythromycin-resistant mutants in severalmip1 strains, indicating the
complexity of the pathways involved in maintaining mtDNA stability.
Notably, the current evidence indicates that the human orthologs of
Rev1, Rev3, and Rev7 do not localize to mitochondria in human
cells [94].
Finally, the ﬁrst report on the mitochondrial localization and
function of another TLS polymerase in yeast cells has been published
[104]. Polymerase η can accurately and efﬁciently bypass UV-induced
cyclobutane thymine dimers in both yeast and human cells [105,106].
In the study by Chatterjee et al. [104], polymerase η (Rad30) localized
to yeast mitochondria and, together with polymerase ζ, prevented
the accumulation of UV-induced point mutations. However, mito-
chondrial Rad30 also prevents the UV-induced instability of rhoþ
genomes responsible for increased petitemutant generation upon UV
exposure, thereby opposing the activity of polymerase ζ (see above).
Thus, Rad30 appears to act in at least two mtDNA repair pathways:
one pathway reduces UV-induced base substitutions, presumably
with polymerase ζ in two-step TLS, as has been proposed for other
TLS polymerases [107], and the other pathway counteracts UV-
induced rearrangements of mtDNA (that lead to petite formation)
by an unknown mechanism. Whether polymerase η functions in the
mitochondria of mammalian cells is unknown.
Mitochondrial base excision repair (mtBER)
Short-patch BER is mediated by monofunctional and bifunctional
glycosylases
A prevalent form of DNA lesions, in both the nuclear and the
mitochondrial DNA of all aerobic organisms, is damage to bases caused
by endogenously produced metabolic by-products, including ROS, or
by exogenous genotoxic agents. If they do not distort the DNA helix,
these lesions are primarily repaired by BER [108,109]. BER is thought
to be the simplest and best-characterized repair pathway; however,
recent advances in the understanding of the association between BER
and single-strand break repair, which processes various termini that
cannot be ligated, challenge this view [110]. The mtBER pathway
operates as one of the main repair mechanisms in mitochondria of all
eukaryotic organisms, although in mammalian cells, the mtBER
system seems to be more complex and versatile than that in
S. cerevisiae cells (Table 1). The repair of mtDNA in mammalian cells
was the subject of excellent reviews by Kazak et al. [117] and Sykora
et al. [118].
The basic BER pathway comprises four steps: (1) base lesion
recognition and excision by a DNA glycosylase followed by cleavage of
the resulting abasic site, (2) DNA end-processing, (3) gap-ﬁlling, and
(4) ligation. Nonbulky base modiﬁcations following oxidation, deami-
nation, and alkylation are recognized by specialized DNA glycosylases.
The proteins belong to a large family of enzymes that cleave the N-
glycosylic bond linking a speciﬁc type of modiﬁed DNA base to
deoxyribose within the sugar–phosphate backbone of DNA. The DNA
glycosylases (DGs) are categorized into two groups: monofunctional
and bifunctional. The monofunctional DG cleaves the N-glycosylic
bond, leaving an intact abasic (apurinic/apyrimidinic; AP) site in DNA
and the free base as the product. The bifunctional DG cleaves the N-
glycosylic bond and the phosphodiester backbone via AP lyase activity
(see below).
In yeast mitochondria, the one monofunctional DG, Ung1,
removes uracil generated by cytosine deamination (removal of U:
G mispairs) or misincorporated dUMP [125,126]. Similar to almost
all mtBER enzymes in yeast, with the exception of mitochondrial
polymerase, the Ung1 glycosylase localizes to both the nucleus and
the mitochondria. The inactivation of the UNG1 gene leads only to a
modestly increased frequency of nonrespiring mutants (the authors
of the cited study state that the mutants maintain intact mitochon-
drial genomes) and a virtually unchanged accumulation of point
mutations in mtDNA, conferring resistance to erythromycin com-
pared to the wild-type strain. Interestingly, the overexpression of
UNG1 increased the frequency of mutations in the mtDNA, suggest-
ing that the elevated level of the Ung1 glycosylase is mutagenic
[126]. Monofunctional glycosylases cleave only N-glycosylic bonds,
at which point Apn1, the AP endonuclease in S. cerevisiae mito-
chondria [127], cuts the phosphodiester backbone to generate a
strand break with 30-OH and 50-dRP ends [reviewed in [120]]. The
repair can then be completed by either short-patch (SP)/single-
nucleotide or long-patch (LP) BER. The distinction between these
two alternative pathways is the size of the patch being repaired:
one nucleotide in the case of SP BER, as described above, and two or
more nucleotides in the case of LP BER [reviewed in [110]]. First, we
describe the former pathway.
Upon AP endonuclease incision of an AP site, 30-OH can serve as an
appropriate substrate for DNA synthesis or ligation, but the 50-dRP
end blocks ligation and must be processed further to generate a 50-
phosphate. The conserved catalytic subunits of polymerase γ from
various organisms have 50-dRP lyase activity [55]. The 50-dRP lyase
converts 50-dRP to a ligatable 50-phosphate. Two bifunctional glyco-
sylases have been identiﬁed in S. cerevisiae mitochondria: Ogg1
excises an abundant oxidative lesion in DNA, 7,8-dihydro-8-oxo-20-
deoxyguanine (8-oxoG), opposite to cytosine [128], and Ntg1, which is
a homolog of Escherichia coli endonuclease III, cleaves oxidized
pyrimidines [129]. These proteins have both glycosylase and AP lyase
activities. Thus, upon removal of the damaged base, Ogg1 and Ntg1
cut the DNA backbone 30 to the AP site and generate single-nucleotide
gapped DNAwith 30-phospho-α,β-unsaturated aldehyde (30-PUA) and
50-phosphate groups at the ends through a β-elimination mechanism.
In this scenario, 30-PUA blocks DNA synthesis and must be processed
by the 30-phosphodiesterase activity of Apn1 before DNA polymerase
can resume synthesis. In the case of repair initiated by a monofunc-
tional DG, the 50-dRP lyase successfully converts the 50-blocked group
to 50-phosphate, or in the case of repair initiated by a bifunctional DG,
the 30-phosphodiesterase activity of the AP endonuclease converts 30-
PUA to 30-OH. In both subpathways of SP BER, the latter group can be
used as a substrate by a DNA polymerase to ﬁll the single-nucleotide
gap generated by base excision and cleavage of the phosphate–sugar
backbone. In yeast mitochondria, the gap-ﬁlling polymerase is prob-
ably polymerase γ, Mip1; however, as mentioned above, more
polymerases (e.g., Rev1 and polymerases α, η, ζ) are present than
just the main mitochondrial replicative polymerase. Whether these
polymerases compete with Mip1 to ﬁll gaps during BER remains to be
determined. Finally, in yeast mitochondria, the essential nuclear–
mitochondrial ATP-dependent ligase Cdc9 links the 50 and 30 ends to
restore a continuous DNA strand [130].
In S. cerevisiae, deletions of the genes encoding the two bifunc-
tional glycosylases, Ogg1 and Ntg1, on their own do not lead to
strong spontaneous mitochondrial mutator phenotypes. Inactivation
of the OGG1 gene was reported several times in the context of the
effect on mitochondrial genome stability. The mitochondrial pheno-
type exhibited by the ogg1Δ deletion strains appears to depend on
some unknown features of the genetic background. Singh et al. [131]
reported that a deletion of OGG1 in their laboratory strain led to a
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Table 1
Comparison of the proteins responsible for the maintenance and stability of the mitochondrial genome across phyla.
Saccharomyces
cerevisiae
Candida
albicans
Homo sapiens Kegg ID and description (for human
proteins)
Associated diseases (number of associated diseases)
Mitochondrial replicative
proteins
Pol γ Mip1 Mip1 POLG1 Polymerase (DNA directed), γ (EC 2.7.7.7)(23) e.g., chronic progressive external ophthalmoplegia
(PEO), ataxia, Alpers syndrome, Parkinson disease
Pol γ-associated subunit POLG2 Polymerase (DNA directed), γ2, accessory
subunit (EC 2.7.7.7)
(6) e.g., PEO with mtDNA deletions autosomal dominant,
Alpers syndrome
DNA helicase Twinkle TWINKLE Chromosome 10 open reading frame 2
(EC 3.6.4.12)
(11) e.g., PEO autosomal dominant, spinocerebellar ataxia,
infantile onset spinocerebellar ataxia
ssDNA-binding protein Rim1 Rim1 SSBP1 Single-stranded DNA binding protein 1,
mitochondrial
Main nucleoid protein Abf2 Gcf1 TFAM Transcription factor A, mitochondrial
BER enzyme Ogg1 Ogg1 OGG1 8-Oxoguanine DNA glycosylase (EC
4.2.99.18)
(55) e.g., renal cell carcinoma (somatic), Cockayne syndrome,
familial adenomatous polyposis, cholangiocarcinoma, lung
cancer
BER enzyme Ntg1 — NTHL1a nth endonuclease III-like 1 (Escherichia
coli) (EC 4.2.99.18)
(5) e.g., primary sclerosing cholangitis, sclerosing cholangitis
BER enzyme Apn1 Apn1 APEX1a APEX nuclease (multifunctional DNA
repair enzyme) 1 (EC 4.2.99.18)
(15) e.g., amyotrophic lateral sclerosis, breast cancer, cystic
ﬁbrosis, respiratory failure, attenuated familial adenomatous
polyposis
BER enzyme Ung1 Ung1 UNG Uracil-DNA glycosylase (EC 3.2.2.27) (12) e.g., immunodeﬁciency with hyper Igm type 5, colon
adenocarcinoma, colorectal cancer, Bloom syndrome, rubella,
congenital rubella
BER enzyme — — MUTYH mutY homolog (E. coli) (EC 3.2.2.–) (63) e.g., multiple colorectal adenomas, MUTYH-associated
polyposis, familial adenomatous polyposis, gastric cancer
(somatic), familial colorectal cancer
BER enzyme — — NEIL1 nei endonuclease VIII-like 1 (homolog of
E. coli NEI) (EC 4.2.99.18)
(15) e.g., primary sclerosing cholangitis, sclerosing
cholangitis, familial colorectal cancer, steroid-resistant
nephrotic syndrome
BER enzyme — — NEIL2 nei endonuclease VIII-like 2 (homolog of
E. coli NEI) (EC 4.2.99.18)
Long-patch BER Rad27 Rad27 FEN1 Flap structure-speciﬁc endonuclease 1
(EC 3.1.–.–)
(11) e.g., Werner syndrome, vitelliform macular dystrophy,
macular dystrophy
Nuclease Nuc1 Nuc1 EXOG (LP
BER)
Endo/exonuclease (50–30), endonuclease
G-like (EC 3.1.30.–)
Nuclease Nuc1 Nuc1 ENDOG
(mtDNA
degrada-
tion?)
Endonuclease G (EC 3.1.30.-) (8) e.g., osteosarcoma, mitochondrial disorders
LP BER, Okazaki FP Dna2 Dna2 DNA2 DNA replication helicase/nuclease
2 homolog (yeast) (EC 3.6.4.12)
(5) e.g., PEO with mtDNA deletions autosomal dominant,
Seckel syndrome type 8
Okazaki FP, other role in
replication?
Pif1 orf19.6133 PIF1 PIF1 50–30 DNA helicase homolog (S.
cerevisiae) (EC 3.6.4.12)
SSB repair Rad28b orf19.268 ERCC8 Excision repair cross-complementing
rodent repair deﬁciency,
complementation group 8 (Cockayne
syndrome A)
(8) e.g., Cockayne syndrome, UV-sensitive syndrome 2,
xeroderma pigmentosum, group C
SSB repair Rad26b Rad26 ERCC6 Excision repair cross-complementing
rodent repair deﬁciency,
complementation group 6 (Cockayne
syndrome B)
(21) e.g., Cockayne syndrome type II, cerebro-
oculofacioskeletal syndrome, xeroderma pigmentosum, UV-
sensitive syndrome 1, age-related macular degeneration, lung
cancer
SSB repair Hnt3b Hnt3 APTX Aprataxin (EC 3.–.–.–) (12) e.g., APTX-related coenzyme Q10 deﬁciency, early-onset
ataxia with oculomotor apraxia and hypoalbuminemia,
ataxia, apraxia, Friedreich ataxia
SSB repair Tdp1b — TDP1 Tyrosyl-DNA phosphodiesterase 1 (EC
3.1.4)
(10) e.g., spinocerebellar ataxia with axonal neuropathy,
autosomal recessive, Ollier disease, spinocerebellar
degeneration
Mismatch repair Msh1 Msh1 Not present;
MSH5c
mutS homolog 5 (E. coli) (5) e.g., premature ovarian failure, common variable
immunodeﬁciency
Mismatch repair: recognition
of single-base mismatches
and small insertion/deletion
loops
Msh1 YBX1a Y box binding protein 1
Transcription/replication
pausing
? ? mTERF1–3d Mitochondrial transcription termination
factors
mTERF1 (1), e.g., Melas syndrome
DSB repair Mre11 Mre11 MRE11 MRE11 meiotic recombination 11
homolog A (S. cerevisiae)
(13) e.g., ataxia telangiectasia-like syndrome
DSB repair Yku70 Yku70/
Hdf1
XRCC6 X-ray repair complementing defective
repair in Chinese hamster cells 6
(4) e.g., systemic lupus erythematosus
DSB repair Yku80b Yku80/
orf19.2383
XRCC5 X-ray repair complementing defective
repair in Chinese hamster cells 5 (DSB
rejoining)
(11) e.g., tinea capitis
DSB repair Rad51b Rad51 RAD51 RAD51 recombinase (58) e.g., breast cancer, Bloom syndrome, mirror movements
All of the information listed is available in [111–116]. The reader is referred to these sources, as well as the references therein, for further details. More reference information
on the human proteins can be found in [117,118]. The names of human proteins follow the HUGO Gene Nomenclature Committee guidelines. There are no data on the
mitochondrial localization of the listed C. albicans proteins, with the exception of Gcf1 [124].
a A functional equivalent rather than a strict homolog of the S. cerevisiae protein (NTHL1 reviewed in [119], APEX1 reviewed in [119,120], YBX1 reviewed in [121]).
b Mitochondrial localization was not shown or is not obvious.
c A homolog of the S. cerevisiae, but it is unknown whether it is a functional equivalent [122].
d There are no homologs in fungi; present in metazoans and plants [123].
2-fold increase in the generation of spontaneous rho petitemutants
compared with the wild-type strain, but increased point mutagen-
esis of mtDNA measured by the frequency of erythromycin-resistant
mutants was not observed. Thus, in that genetic background, the
absence of Ogg1 in mitochondria results in an increased incidence of
mitochondrial genome rearrangements but no difference in point
mutations of the G-T transversion type that are typically induced
by unrepaired 8-oxoG lesions [128]. However, Dzierzbicki et al. [20]
showed in another strain that the inactivation of OGG1 leads to a
10-fold increase in mitochondrial point mutations that confer
resistance to oligomycin; however, consistent with the previous
report, they did not observe an increased incidence of erythromycin-
resistant mutants in the ogg1Δ strain cultures. The group also
determined that G-T transversions in the mitochondrial target
gene OLI1 were 10 times more frequent in ogg1Δ cells than in wild-
type cells. In the third study [21], Pogorzala et al. inactivated the
OGG1 gene in yet another strain. In that strain, the deletion of OGG1
caused a signiﬁcant severalfold increase in the frequency of mito-
chondrial erythromycin-resistance point mutations. Interestingly,
despite the differences in all three studies, mitochondrial ogg1Δ-
speciﬁc phenotypes were suppressed by the concomitant deletion of
the NTG1 gene, suggesting that the two glycosylases, which have
diverse substrate speciﬁcities (see above), compete for the same
substrate. Notably, Sandigursky et al. [132] reported that puriﬁed
yeast Ogg1 efﬁciently removed sugar–phosphate residues at incised
30-AP sites during the AP lyase reaction (i.e., the enzyme has
deoxyribophosphodiesterase activity that removes the 30 unsatu-
rated aldehydic group, described as 30-PUA above, leaving a 30-OH).
Therefore, the Ogg1 enzyme may be endowed with three activities
that allow it to efﬁciently process its cognate lesion and leave a one-
nucleotide gap that can readily be ﬁlled by a DNA polymerase
without the need for any AP endonuclease activity. Consequently, if
Ogg1 cleaves the modiﬁed base, the repair is accomplished efﬁ-
ciently by the enzyme to replace the damaged base with the correct
one. However, when Ntg1 excises the base instead of Ogg1, a
mutagenic product, which is probably the blocking end 30-PUA, is
generated after the AP lyase reaction. As for the identity of the
modiﬁed base recognized by both Ogg1 and Ntg1, yeast Ogg1 is
thought to be an 8-oxo-guanine DNA glycosylase, but it also excises
2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy-G [128]),
which, together with Fapy-A (4,6-diamino-5-formamidopyrimidine),
is one of the major lesions generated in DNA by hydroxyl radical
attack and UV radiation [133]. Ntg1 has also been shown to excise
Fapy-G (but not 8-oxoG opposite cytosine) along with Fapy-A and a
number of modiﬁed pyrimidines [129]. The true biological effects of
both Fapy-A and Fapy-G have been recognized only recently [133].
Both lesions lead to misincorporations and do not block DNA chain
elongation, as was believed for a long time. Polymerases misincor-
porate adenine paired with Fapy-G, resulting in G-T transversions.
Therefore, this change is the same type of mutation as that caused
by 8-oxoG [128]. Thus, the modiﬁed lesion recognized by both Ogg1
and Ntg1 is probably Fapy-G, but its excision by Ntg1 produces a
promutagenic intermediate that may produce either point muta-
tions or genome rearrangements, depending on the genetic back-
ground. Because the most likely promutagenic intermediate
produced by Ntg1 is the 30-blocked end produced in the AP lyase
reaction, Ntg1 may share a pathway with Apn1, the downstream
component of the SP BER pathway, in this promutagenic processing
of Fapy-G. This argument is supported by the observation that the
inactivation of either NTG1 or APN1 suppresses the increase in point
mutagenesis in the ogg1Δ strain [21]. Nevertheless, these results are
difﬁcult to generalize because both the phenotypes and the inter-
actions among deletions of the three genes and other genes engaged
in mtDNA repair seem to be largely genetic context-dependent
[21,36]. Therefore, in the discussion below, we stress only the
consistent evidence.
Several other studies have implicated Ntg1 glycosylase in the
production of promutagenic or recombinogenic intermediates. Upon
hydrogen peroxide treatment of isolated mitochondria, Ntg1 was
reported to be responsible for generating DSBs (in an enzymatically
unclear reaction) in the mitochondrial origin of replication ori5,
which initiates Mhr1-dependent recombination and leads to an
increased mtDNA copy number in response to oxidative stress
[71,134]. Consistently, Schroeder and Shadel [135] recently showed
that ntg1Δ strains exhibit a decreased mtDNA copy number in
comparison to that of the reference strains, although the ntg1Δ
strains do not exhibit a respiration defect. Phadnis et al. [136]
reported that the loss of Ntg1 suppressed mitochondrial point
mutations, frameshift mutations measured by mitochondrial micro-
satellite instability, and deletions in mtDNA between direct repeats,
supporting the conclusion that the products of the broad-speciﬁcity
Ntg1-mediated AP lyase activity may contribute to mtDNA instability.
The overexpression of APN1 in the wild-type strain led to decreased
point mutagenesis in the mtDNA, suggesting that downstream BER
reactions are rate-limiting for the efﬁcient completion of lesion
processing by mitochondrial BER pathways under these conditions.
In contrast, the overproduction of Apn1 in an ntg1Δ strain signiﬁ-
cantly increased the level of mitochondrial point mutations, indicat-
ing that Apn1 also generates mutagenic intermediates in the absence
of Ntg1 glycosylase. In ntg1Δ cells, the products that are generated in
wild-type cells by Ntg1-mediated AP lyase reactions do not accumu-
late, and the Apn1 endonuclease is diverted to other potential sites of
action. The enzyme is endowed with a variety of activities associated
with processing strand breaks involving blocked 30 termini [reviewed
in 120]. The enzyme can also directly cut the DNA strand upstream of
the primary lesion (independent of N-glycosylases) in a process
termed nucleotide incision repair that leaves the damaged base on
a 50-ﬂap that may be processed further by LP BER (see below).
Consistent with the reports by Phadnis et al. [136] and Pogorzala
et al. [21], another study of mitochondrial microsatellite instability in
yeast cells showed that Apn1 overproduction causes increased poly
(GT) microsatellite instability in mtDNA, probably by converting AP
sites and oxidized bases into more toxic strand breaks. This effect
was counteracted by Ogg1 overexpression [127]. According to other
reports, the loss of the APN1 gene leads to only a weak increase, at
most, in the level of spontaneous point mutations [36,137], but a
signiﬁcant increase is observed in the number of mitochondrial
mutations induced upon exposure to the alkylating agent methyl
methanesulfonate [137,138]. These results indicate that Apn1 in
mitochondria is involved in the repair of alkylation-induced lesions
in the mtDNA, as in the nucleus. Other factors that interact with
Apn1 during MMS-induced lesion repair in yeast mitochondria
remain unknown.
With regard to short-patch mtBER in yeast cells, it may seem
puzzling that yeast strains lacking mtBER enzymes that were
conservatively maintained in the mitochondrial compartment dur-
ing the evolution of eukaryotic cells do not exhibit any strong
mitochondrial phenotypes indicating the signiﬁcant disruption of
mtDNA stability. On the contrary, under certain circumstances, the
partial absence of BER enzymes seems to stabilize mtDNA. However,
the characterization of yeast mtBER was restricted mostly to
studying various single haploid deletion mutants under standard
laboratory conditions of relative nutrient abundance and comfort, in
other words, under conditions that are entirely artiﬁcial for yeast
cells. For the most part, natural yeast habitats are harsher than
laboratory conditions, and yeast cells are frequently exposed to
various chemical or physical mutagenic factors that may damage
mtDNA. Additionally, S. cerevisiae cells are usually diploid, which
may be relevant for mtDNA stability [31]. Are the artiﬁcial labora-
tory conditions of our experiments with yeast the reason for the
apparent paucity of mitochondrial phenotypes in mtBER mutants?
This question cannot be answered until it can be experimentally
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tested. The above-cited studies on MMS-induced mtDNA mutagen-
esis [61,137,138] and oxidative damage in mtDNA [88] show that
using an appropriate deleterious agent to increase the level of
speciﬁc DNA damage can reveal the functions of various mtDNA
repair pathways that are usually weakly detectable. There is another
reason that can explain why so many deletions of genes encoding
mitochondrial proteins are not associated with discernible pheno-
types. The redundancy of biochemical pathways contributes sub-
stantially to the robustness of cellular systems. Although several
reports studied mutations in two separate mtDNA repair pathways,
the redundancies of these mitochondrial processes remain largely
unexplored. For example, the lack of Ntg1 glycosylase combined
with a pif1-null allele or abf2-null allele led to a signiﬁcantly
increased frequency of petite mutations in comparison to either
single mutant [19]. The mechanism for this process remains
unknown, although it is presumably associated with the role of
Ntg1 in the regulation of mtDNA copy number [135], as mentioned
above. These results would imply that the Pif1 helicase and Abf2
protein function in one or more pathways independent of an Ntg1-
dependent pathway involved in the maintenance of rhoþ mtDNA
and the stability of its sequence. This example clearly shows that a
mitochondrial DNA repair pathway can be fully understood only in
the context of other related pathways.
Long-patch BER
The BER pathway described above falls into the category of
short-patch/single-nucleotide BER, but long-patch BER is an alter-
native pathway. This repair pathway is required if the 50 end
generated in the ﬁrst steps of BER (i.e., base excision and AP lyase-
mediated strand cleavage of the resulting AP site), usually 50-dRP,
cannot be removed by the polymerase, e.g., the end is further
oxidized. In this case, the 50-blocking group could be removed by
the 50-ﬂap endonuclease 1 (Rad27 in yeast cells; FEN-1 in
mammalian cells), which is also known to be involved in removing
50-RNA primers from Okazaki fragments during DNA replication.
However, before the ﬂap endonuclease can act, the 50-blocking
group has to be converted into a 50-ﬂap by strand-displacement
synthesis performed by one of the DNA polymerases, mainly yeast
polymerase γ [54]. In the nuclei of mammalian cells, the LP BER
steps other than ﬂap cleavage are identical to those of DNA
replication, involving DNA polymerases δ/ε and nuclear DNA
ligase I. These enzymes, including FEN-1, are recruited by the
sliding clamp PCNA that enhances their activity. Several recent
studies reported the identities of three mammalian mitochondrial
LP BER enzymes: ﬂap endonuclease FEN-1 [84], a second ﬂap
endonuclease DNA2 [139,140], and 50-exo/endonuclease EXOG
[141]. Nevertheless, the precise contribution of these nucleases
to mitochondrial LP BER remains controversial. EXOG, an ssDNA
nuclease and a paralog of endonuclease G (ENDOG), was impli-
cated in the removal of the 50-blocking residue and is required for
repairing endogenous SSBs in the mitochondrial genome [141].
Interestingly, EXOG depletion induces persistent SSBs in the
mtDNA, enhances ROS levels, and induces apoptosis in normal
cells but not in cells devoid of mtDNA. This ﬁnding suggests that
persistent SSBs in the mitochondrial genome alone could trigger
apoptotic signaling in mammalian cells. Establishing the precise
roles of these enzymes in maintaining the integrity of the
mitochondrial genome needs further investigation. In particular,
the yeast orthologs of mammalian mitochondrial LP BER proteins
require further study because, somewhat paradoxically, we know
less about LP BER pathways in yeast mitochondria than in
mammalian cells.
The LP BER pathway in the mitochondria of S. cerevisiae cells
remains largely unknown. The ortholog of DNA2, yeast nuclease/
helicase Dna2, was mentioned above. Its role in yeast mitochondria
has not been characterized. In yeast cell nuclei, Rad27 plays a role in
the cleavage of 50-DNA ﬂaps created during Okazaki fragment
processing, in the prevention of sequence duplications and repeat
sequence expansions, in DSB repair by nonhomologous end-joining
(NHEJ), and in the processing of intermediates during nuclear LP BER
[142–145]. The ﬁrst report on Rad27 in yeast mitochondria revealed
unexpected ﬁndings about the mitochondrial function of the endo-
nuclease [78]. Strains lacking Rad27 displayed increased rates of
erythromycin-resistance point mutagenesis but conversely exhibited
decreased instability of microsatellite repeats and less frequent
deletions mediated by direct repeats in mtDNA. These results suggest
that the lack of Rad27 in mitochondria leads to the accumulation of
point mutations, which may be attributed to the largely abolished
mitochondrial LP BER. However, in the absence of Rad27, small-scale
(microsatellite alterations) and large-scale genome rearrangements
(direct-repeat mediated deletions), which are thought to be
mediated mostly by polymerase slippage or template switching, are
strongly inhibited. Rad27 activity may favor polymerase slippage/
template switch events in mitochondria by producing nicks or small
gaps upon 50-ﬂap removal during mitochondrial LP BER. We noticed
that defects in strains lacking Rad27 reproduce the phenotypes of
strains lacking REV3 on a larger scale (although data on the stability
of the DRM(D) reporter in rev3Δ strains are not available), suggesting
that Rad27 and Rev3 may function in the same pathway in
mitochondria. Another interesting experiment would be to verify
whether the mitochondrial mutator phenotype of RAD27 inactivation
depends on the activity of any mitochondrial glycosylase(s) or the AP
endonuclease, because LP BER may be required for the removal of 50-
blocked ends generated by BER pathways. A similar scenario has
been described in the nucleus [143].
The Nuc1 nuclease, an S. cerevisiae ortholog of mammalian
ENDOG and EXOG nucleases [146,147], exhibits both endo- and
50-30 exonuclease activities [148]. Nuc1 is located in the mito-
chondria yet translocates into the nuclei of apoptotic cells [146].
Nuc1 is involved in mtDNA recombination as a 50-30 exonuclease
[149]. A more recent study showed that the generation of
oxidative stress-induced rearrangements in mtDNA is markedly
reduced in strains lacking the NUC1 gene [150]. This observation
suggests that the fate of at least certain types of oxidative lesions
in mtDNA, presumably strand breaks, is dependent on the
activity of the enzyme. Nuc1 can produce recombinogenic DNA
ends by introducing single-strand gaps into dsDNA using its
endonuclease and 50-30 exonuclease activities. Under conditions
of acute oxidative stress accompanied by the shortage of intrami-
tochondrial energy, e.g., in cells treated with antimycin A while
growing on a respiratory substrate, Nuc1 activity may lead to
extensive degradation of damaged mtDNA. Combined with certain
nonallelic recombination events that the Msh1p activity fails to
restrain (see below), this Nuc1p-mediated processing is likely to
be the ﬁrst step that eventually culminates in the formation of
rho petite mutants. Whether Dna2, Rad27, and Nuc1 function in
yeast mitochondria in the LP BER pathway(s) remains to be
established.
Mitochondrial mismatch repair and homologous recombination in
mitochondria
Msh1-dependent pathway
The MSH1 gene encodes a protein that is homologous to the
E. coli MutS protein [151]. Strains lacking the gene exhibit a petite
phenotype due to large-scale mitochondrial genome rearrange-
ments, suggesting that Msh1 plays an important role in the
maintenance of mtDNA stability. The Msh1 protein was character-
ized in vitro as a DNA-binding ATPase that recognizes mismatches
[152]. MutS homologs generally act by initiating the correction of
mismatches that arise during either replication or recombination
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(reviewed in [153]). For the ﬁrst time, the increased accumulation of
point mutations in the mtDNA of mutants defective in Msh1
function was described for an msh1Δ/MSH1 heterozygous strain
[154]. Therefore, theMSH1 gene is haploinsufﬁcient, suggesting that
the Msh1 level is ﬁne-tuned for optimal mitochondrial genome
maintenance. A functional Msh1p is required in yeast mitochondria
to prevent the accumulation of point mutations in mtDNA as a
crucial factor in the proposed, but not-yet-characterized, pathway
of mitochondrial mismatch repair. Furthermore, Msh1p activity
suppresses direct repeat-mediated deletions, thereby inhibiting
genomic rearrangements that may result in defective mtDNA [32].
In addition, a heterozygous msh1Δ/MSH1 strain with poly(GT)
tracts inserted into mtDNA exhibited increased rates of microsatel-
lite repeat-dependent frameshift mutations in mtDNA [30]. How-
ever, high overexpression of the MSH1 gene leads to the instability
of rhoþ genomes by an unknown mechanism, and moderate over-
production of Msh1 increases the stability of poly(GT) tracts [155];
this result is consistent with the opposite destabilization effect in
the partially Msh1-depleted heterozygous strain (see above, [154]).
Moderate MSH1 overexpression also suppresses the mitochondrial
mutator phenotype of an ogg1Δmutant [20] and the mitochondrial
mutator phenotype of a sod2Δ mutant [36]. Moreover, the
increased dosage of wild-type MSH1, but not of mutant alleles
coding for deﬁcient variants of the protein, results in enhanced
allelic mitochondrial HR [36]. In contrast, transformation of the
same MSH1-overexpressing plasmid into a strain with mtDNA
containing the DRM(D) reporter decreased the frequency of direct
repeat-mediated deletions in mtDNA (A. Kaniak-Golik, unpublished
results). Consequently, Msh1 promotes allelic HR in mitochondria
but inhibits nonallelic DRM(D) events and GT-repeat frameshift
rearrangements. We propose that the Msh1 protein scans the
mtDNA duplexes generated during either replication or
recombination-associated strand invasion or strand annealing for
the presence of mismatches and directs the duplexes into either HR
combined with mismatch correction or heteroduplex rejection and
inhibition of the incipient recombination, depending on the quality
of the duplex.
New ﬁndings on mitochondrial recombination pathways in yeast cells
The pathways of mitochondrial recombination in yeast are not
well understood. Our knowledge on the subject has increased by only
a small amount since the review compendium by Contamine and
Picard [14] was published. In this section, we review only the newest
and most signiﬁcant ﬁndings. A recent review by Chen [156] provides
a more general and detailed overview of the current knowledge on
mtDNA recombination in various organisms. We should also acknowl-
edge a recent study, mentioned above, by Fritsch et al. [73] that
promises to provide fresh insight into the mechanisms of mitochon-
drial recombination in the near future. This study presents a new
procedure for using high-throughput sequencing to monitor mtDNA
recombination in diploid yeast cells.
Mre11–Rad50–Xrs2 complex and Ku proteins function in mitoc-
hondria. Two major DSB repair pathways have been studied
extensively, albeit only in nuclear genomes thus far: homo-
logous recombination and nonhomologous end-joining. HR is initiated
when the DSB end is resected by nucleases and helicases to generate 30-
ssDNA overhangs. In the nucleus, the MRX complex (Mre11–Rad50–
Xrs2) initiates 50-end resection, which is further processed by the Exo1
and Dna2–Sgs1 nucleases [86]. The resulting 30-ssDNA overhangs are
used by recombinases to invade homologous duplex DNA for priming
subsequent DNA synthesis. Joint molecule intermediates gen-
erated during HR can be resolved by diverse mechanisms to produce
crossover or noncrossover products [35]. Alternatively, long homologous
30-ssDNA overhangs produced by the resection of repeated sequences
can be annealed with a concomitant deletion of the intervening
sequence between repeats, leading to recombination by a single-
strand annealing mechanism (see above reference). This mechanism
represents one possible source of genome rearrangements. In NHEJ, DSB
ends are blocked from 50-end resection by bound Ku proteins, Yku70
and Yku80, which form a heterodimer. The Ku heterodimer promotes
direct ligation of the DSB ends, but NHEJ is error prone and frequently
results in small insertions, deletions, and substitutions at the joint site
[157]. Both the HR and the NHEJ pathways may lead to genome
rearrangements when they rely on nonallelic sequences.
The most signiﬁcant new ﬁnding indicating the involvement of
HR and NHEJ in maintaining the stability of mtDNA was reported
by Kalifa et al. [158]. The authors showed that the inactivation of
crucial DSB repair pathways mediated by the MRX complex and Ku
proteins synergistically decreased the rate of DRM(D) deletions in
yeast mtDNA. The results suggest that these deletions originate
mostly from the processing of DSB lesions in the repeated
sequences by two independent pathways: mitochondrial MRX
and mitochondrial Ku proteins. Surprisingly, the decrease in
DRM deletions in mtDNA in a strain lacking both the MRX and
the Ku complexes was associated with a modest, although sig-
niﬁcant, increase in spontaneous petite mutants. These results
indicate that the mechanisms of DRM deletions and rearrange-
ments responsible for petite formation are mechanistically differ-
ent, and under these conditions, both pathways, mitochondrial HR
and NHEJ, contribute to a certain extent to the maintenance of the
rhoþ genome. However, a current report by Dzierzbicki et al. [150]
showed that mutants deﬁcient in MRX function displayed
increased susceptibility to oxidative stress-induced rearrange-
ments in mtDNA in antimycin A-treated cells. Under these condi-
tions, the inactivation of RAD50 was epistatic to a YKU70 deletion.
The increased petite generation in cultures of antimycin A-treated
rad50Δ cells correlated with their decreased potential for sustain-
ing mitochondrial allelic HR. Thus, under certain conditions, the
mitochondrial Rad50-dependent pathway plays a signiﬁcant role
in the maintenance of rhoþ mtDNA. Other factors acting in this
mtDNA repair pathway remain to be established. Similarly, the
components of mitochondrial NHEJ have not been identiﬁed.
Mechanisms that generate deletions in mitochondrial DNA have
been intensively studied in mammalian cells subjected to oxidative
stress during aging and disease (reviewed in [159]). Deletions are
usually ﬂanked by direct repeats, suggesting that these repeats may
be involved in the formation of deletions. Two mechanisms are
considered for the generation of mtDNA deletions: (1) polymerase
slippage on repeated sequences or (2) DSB repair between repeats.
However, mtDNA deletions have been suggested as being more likely
to occur during DSB repair of damaged DNA rather than during
replication [159]. The presence of multiple homology-dependent and
homology-independent (NHEJ?) pathways underlying DSB repair was
proposed to explain the observed patterns of mtDNA deletions
[160,161]. Therefore, yeast cells may provide a good model system
for studying mitochondrial pathways of DSB repair and the genera-
tion of mtDNA deletions.
Mgm101, a Rad52-like protein, functions not only in mitochondria but
also in the nucleus. The mitochondrial nucleoid protein Mgm101 has
been known for some time to be essential for the maintenance of rhoþ
mtDNA but not rho genomes [162]. Mgm101-deﬁcient cells were
more sensitive to mtDNA damage induced by UV irradiation and were
hypersensitive to mtDNA damage induced by γ rays and hydrogen
peroxide treatment. Consequently, Mgm101 was proposed to perform
an essential function in the repair of oxidatively damaged mtDNA that
is crucial to maintaining the mitochondrial genome [163]. Recently,
new evidence was published [164], showing that Mgm101 shares
conserved motifs with the N-terminal ssDNA-annealing (SSA) domain
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–104 83
of the yeast Rad52 protein. Rad52 is known mostly as a mediator of
Rad51 recombinase activity in the nucleus, but the protein also has SSA
activity. Consistently, the authors demonstrated that puriﬁed Mgm101
promotes SSA reactions in vitro in the presence of the mitochondrial
ssDNA-binding protein Rim1. Moreover, Mgm101-deﬁcient cells
exhibited decreased rates of repeat-mediated deletions in mtDNA
(the DRM(D) reporter). This observation agrees with previous
conclusions indicating the predominantly noncrossover character of
deletions found in the mitochondrial DRM(D) reporter [33] and
correlates with the notion that a mitochondrial SSA pathway
participates in repeat-mediated deletion events. The elucidation of
mitochondrial Mgm101 function will shed light on the role of
recombination-related processes for the maintenance and repair of
mtDNA. Surprisingly, a new function of Mgm101 in an unexpected
location has recently been reported. The protein was shown to form a
complex with the FANCM ortholog Mph1 helicase and MutSα (Msh2–
Msh6 complex) in the nucleus and participate in the recombination-
dependent repair of interstrand crosslink lesions in nuclear DNA [165].
Does Mgm101 function in an analogous pathway in yeast
mitochondria? If so, does Msh1 replace the nuclear MutSα in this
mitochondrial Mgm101-dependent process? Which mitochondrial
helicase associates with Mgm101 in mitochondria? These and other
questions concerning Mgm101 should be addressed soon by
researchers studying mtDNA repair pathways in budding yeast.
Degradation of mtDNA in the network of mtDNA maintenance
pathways
Because the generation of antimycin A-induced large-scale dele-
tions in mtDNA has been reported to be dependent on the Nuc1
protein [150], one possibility is that under conditions of oxidative
stress, Nuc1 may be involved in the selective degradation of damaged
copies of mtDNA. Previously, mitochondria were postulated to be
capable of removing damaged mtDNA owing to the presence of
multiple copies of mtDNA. More speciﬁcally, the mtDNA damage-
inducible nuclease Din7p, a paralog of Rad27 and other Rad2 family
nucleases, was suggested as a good candidate to accomplish this goal
[166]. In addition, degradation processes operate on oxidatively
damaged mtDNA in mammalian cells [167]. Presumably, the degrada-
tion of oxidatively damaged mtDNA, together with mtDNA repair
pathways such as mtBER, may represent a component of complex
machinery that is responsible for protecting the mitochondrial gen-
ome integrity. At present, evidence supports another mechanism of
mitochondrial degradation. This process is an autophagy-dependent,
mitochondria-speciﬁc degradation pathway mediated by Atg32 and
Atg11 that has been shown to be important for preventing the
accumulation of cytoplasmic petite mutants in nitrogen-starved cul-
tures [168]. The authors suggested that under these conditions, the
mitophagy pathway simply degrades excess mitochondria to suppress
ROS production and mtDNA damage. Future studies should elucidate
the connections between the mitochondrial nucleases mentioned
above and the mitophagy pathway, if such connections exist.
Mitochondrial inﬂuence on the nuclear genome
Functional mitochondria are crucial to maintaining the stability
of cellular genetic information. This requirement is not limited to
the mitochondrial genome, which encodes organellar rRNA, tRNA,
and a handful of proteins including components of the respiratory
chain, proteins needed in large amounts intramitochondrially, or
proteins whose expression needs tight feedback control. Func-
tional mitochondria are also important for the stability of the
nuclear genome. In yeast cells, mitochondrial dysfunction leads to
a nuclear mutator phenotype (measured by the frequency of
canavanine-resistant colonies), regardless of whether this
dysfunction can be attributed to blocking oxidative phosphoryla-
tion by antimycin A at mitochondrial complex III, deletions in
mtDNA (rho), or the complete loss of mtDNA (rho0) [12]. Super-
ﬁcially, it can be assumed that a dysfunctional mitochondrion
generates reactive oxygen species, which will cause a severalfold
increase in the nuclear mutation level. However, this simple
explanation is not applicable here. Although antimycin A treat-
ment leads to increased intracellular ROS levels, the intracellular
levels of ROS are decreased in rho and rho0 strains. Moreover,
nuclear mutations arising in rho0 cells depend on the Rev1 protein
and DNA polymerase ζ, whereas those resulting from antimycin A
treatment do not. In a recent study, Dirick et al. [169] showed that
the genomic instability speciﬁc to rho0 diploid cells is due to DNA
breaks and mitotic recombination, occurs mostly in nondividing
cells, and tends to ﬂuctuate depending on the environmental
conditions. Consequently, mitochondrial dysfunction is mutagenic,
and multiple pathways are likely to be responsible for the result-
ing nuclear mutator phenotype. Similar conclusions can be drawn
from other studies showing that ROS elevation due to mitochon-
drial disorder and subsequent oxidative damage causes destabili-
zation of the mitochondrial and/or nuclear genome [170,171].
Other studies have shown that the nuclear DNA instability
phenotype is not generated by mitochondrial ROS and instead
have implicated such processes as dNTP production [172], iron–
sulfur cluster formation [11], metal ion detoxiﬁcation/homeostasis
[173], or apoptosis disturbances [174]. How does the mitochon-
drion inﬂuence nuclear genome stability? The mitochondrion
affects stability in a number of ways. After time and according to
distinctive kinetics, every malfunction of a mitochondrial process
can provoke mitochondrial disorder, which in turn leads to
genome instability. In the following sections, this concept will be
supported with numerous examples.
When considering mitochondrial dysfunction, it is important to
differentiate between a mutation in a single mitochondrial gene
encoding a component of the respiratory chain, which is necessary
for proper mitochondrial function, and rho or rho0 mutations. All
of these mutations affect cellular energy production by oxidative
phosphorylation, but the former preserves the mitochondrial
genome and the production of mitochondrially encoded proteins,
whereas the latter disrupt the ability to synthesize those proteins
(components of the mitochondrial translation apparatus that are
required for the process are also encoded by mtDNA, see Intro-
duction). Respiratory-deﬁcient rhoþ mutants do not exhibit as
robust a nuclear mutator phenotype as that of rho0 strains
[11,169]. Therefore, a mere respiratory deﬁciency is not sufﬁcient
for marked genomic instability. Whether rho strains exhibit the
nuclear mutator phenotype of rho0 cells or that of respiratory-
deﬁcient rhoþ cells has not been reported. Interestingly, increasing
the inner mitochondrial membrane potential (ΔΨ) stabilizes the
nuclear genome of rho0 cells [11,169], suggesting that a deﬁciency
in an essential cell-viability mitochondrial function is associated
with the nuclear instability of rho0 strains.
Mutations that affect both the mitochondrial and the nuclear
genomes
Certain genes are indispensable for maintaining both the mito-
chondrial and the nuclear genomes. Mutations in these genes may
result in mtDNA damage and lead to mitochondrial genome loss
and mitochondria dysfunction through a sequence of steps. Because
these mutations affect the nuclear genome simultaneously, the
extent to which mitochondrial dysfunction contributes to nuclear
genome destabilization is difﬁcult to determine. The products of
these genes include proteins involved in various pathways of DNA
repair, e.g., the catalytic subunit of DNA polymerase ζ Rev3, which is
engaged in postreplication repair [94,99,103]; the Mre11–Rad50–
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Xrs2 and Yku70/80 complexes, which are responsible for DSB repair
via NHEJ [158]; the uracil-DNA glycosylase Ung1, which is respon-
sible for the repair of uracil in DNA formed by spontaneous cytosine
deamination [126]; and Ogg1 and Ntg1 glycosylases, as well as the
AP-endonuclease Apn1, which are involved in oxidative DNA
damage removal via BER [127,136,137].
Mutations that perturb the mitochondrial and nuclear genomes in
various ways
The next class of mutations affects genes whose products play
distinct roles in mitochondria and the nucleus. For example, a
mutation in the DEF1 gene (encoding a protein involved in DNA
damage-induced degradation of RNA polymerase II) leads to
mtDNA loss (rho0 phenotype), whereas the same mutation inﬂu-
ences telomere length in nuclear DNA. The reintroduction of a
wild-type copy of the DEF1 gene into def1Δ mutant cells stimu-
lates telomere elongation but is unable to restore the rhoþ
phenotype. This result shows that the telomere-shortening effect
in def1Δ cells is not a consequence of mtDNA loss but that both
phenotypes are independent [175]. Another example of a dual-
function protein is homocitrate synthase (Lys20), a mitochondrial
enzyme that catalyzes the ﬁrst step in lysine biosynthesis. Surpris-
ingly, Lys20 also localizes to the nucleus, where it associates with
chromatin and is linked to the key process of DNA damage repair
through the histone acetyltransferase Esa1 and through the alter-
nate histone variant H2A.Z to contribute to histone acetylation and
phosphorylation of the checkpoint protein Rad53, respectively
[176]. The chromatin-linked roles of Lys20 are dependent on its
nuclear localization but independent of its catalytic activity.
However, Lys20 seems to link cellular metabolism with chromatin
function.
Another metabolic link can be found for the fumarase Fum1. This
mitochondrial enzyme is involved in the TCA cycle and has an
alternative cellular distribution. Upon induction of DNA damage, the
cytosolic fumarase fraction is recruited to the nucleus and plays a key
role in the protection of cells from DNA damage, especially from DSBs.
The DNA damage defense potential of fumarase depends on its
enzymatic activity. A lack of Fum1 can be complemented by high
concentrations of its product, fumaric acid [177]. The ﬁnding that
fumaric acid but not malic acid can protect cells from DSBs indicates
that the conversion of malic acid to fumaric acid is the function of
fumarase in the nucleus and suggests that fumaric acid plays a role in
sensing, regulating, and/or stabilizing the cellular response machinery
after DNA damage. In agreement with these results, human fumarase
was found to be a tumor suppressor gene [178]. Our understanding of
how fumarase protect cells against tumors is supported by earlier
data showing that fumarase inhibition leads to elevated intracellular
fumarate. Fumarate acts as a competitive inhibitor of prolyl hydro-
xylase (HPH), the enzyme that stabilizes hypoxia-inducible factor
(HIF), which is a transcription factor that induces the expression of
angiogenesis-regulated genes [179]. In mouse embryo ﬁbroblasts
lacking fumarase, fumarate accumulation leads to AMP-activated
protein kinase (AMPK) activation, which protects cells against apop-
tosis [180]. Therefore, these data suggest at least two possible indirect
mechanisms of fumarate-dependent tumorigenesis: (1) a mechanism
mediated by the regulation of HPH activity and HIF protein levels and
(2) a mechanism that relies on the pro-oncogenic role of AMPK.
Mutations that impair mitochondrial functions are important for
nuclear genome maintenance
In the following section, a group of mutations is described that
affects mitochondria and leads to their functional defect, which in
turn destabilizes the nuclear genome. Depending on the primary
mutation and mitochondrial process being affected, various mechan-
isms of nuclear genome instability are possible.
Altered function of the electron transport chain (ETC) can provoke
nuclear genome instability
Genomic DNA destabilization may be caused by all ETC muta-
tions in genes that meet the following criteria:
 they encode components of respiratory chain complexes,
regardless of whether they are encoded by mitochondrial or
nuclear DNA;
 they encode proteins involved in the transport of proteins into
mitochondria;
 they are implicated in mitochondrial protein synthesis;
 they are engaged in protein folding, prosthetic group prepara-
tion, and mounting or functional complex maturation;
 they are involved in the delivery of necessary substrates;
 they prevent macromolecule damage during cellular stress
condition; or
 they inﬂuence ETC gene expression.
This destabilization, however, can be caused by various cellular
pathways. Mitochondrial respiration is the primary source of ROS,
such as superoxide (O2ˉ), hydrogen peroxide (H2O2), or hydroxyl
radical (HOˉ). Electron leakage from the ETC under physiological
conditions is responsible for the conversion of approximately 1–2%
of consumed oxygen molecules into superoxide [181–183]. Uncou-
pling the respiratory chain in response to a deletion in a variety of
genes encoding mitochondrial proteins, e.g., NDE1 (NADH dehy-
drogenase) and FMC1 (involved in ATP synthase complex assem-
bly) [184], or in response to treating cells with an ETC inhibitor
(antimycin A) results in elevated ROS production; these increased
ROS are followed by an increase in endogenous premutagenic DNA
lesion formation, which in turn causes genome destabilization
[12,185]. However, oxidative stress generates DNA lesions, such as
modiﬁed bases (the primary modiﬁcation being 7,8-dihydro-8-
oxoguanine, which leads to GC-TA transversions), abasic sites,
and single-strand DNA breaks. When left unrepaired, these forms
of DNA damage will cause mutations or block the replication fork,
thereby contributing to a number of degenerative processes,
including gross chromosomal rearrangements [186,187]. Impor-
tantly, not all parts of the respiratory chain are involved in ROS
overproduction. Mutations in ATP11 (involved in ATP synthase
complex assembly), COX11 (delivering copper to cytochrome c
oxidase), CYT1 (cytochrome c1), PET117 (cytochrome c oxidase
assembly), RIP1, QCR8 (subunits of ubiquinol cytochrome c reduc-
tase complex), or TCM62 (succinate dehydrogenase complex
assembly) do not produce an elevation of the ROS level [184].
However, these mutations substantially shorten the life span of
cells, make them more sensitive to oxidative stress, and some-
times (atp11, cyt1, pet117, and rip1) even cause them to be unable
to survive on nonfermentable carbon sources. Interestingly, no
signiﬁcant changes in the mitochondrial membrane potential are
detected in these mutants compared to the wild-type strain.
H2O2 treatment can provoke electron leak from the ETC,
although not all parts of the respiratory chain are sensitive to this
effect. Although H2O2 inhibits the activities of complexes II and III
by oxidizing their regulatory SH groups, H2O2 does not affect
complex IV, which is protected by its peroxidase activity. However,
the reaction of H2O2 with complex IV leads to the formation of
sulfur-centered radicals that cause lipoperoxidation, which in turn
speciﬁcally enhances the damage in complex III, stimulates elec-
tron leakage and subsequent O2ˉ production, and causes iron
release from the mitochondrial pool [188]. Therefore, complex III
appears to be the major source of ROS [189] and seems to have an
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–104 85
additional physiological function as a signaling molecule during
adaptation to hypoxia or as an effector during apoptosis.
Despite the potentially destructive role of ROS in the cell, accumu-
lating data suggest their beneﬁcial role as molecular signals to trigger
an adaptive response known as mitohormesis and induce endogenous
defense mechanisms by which the cell acquires increased stress
resistance and longevity [190,191]. Accordingly, antioxidant dietary
supplements that prevent ROS signaling counteract the health-
promoting and life-span-extending capabilities of calorie restriction
and physical exercise.
Incidentally, in human cells, an alternative source of ROS is
complex I, which is not present in yeast. Instead, yeast cells have
two NADH dehydrogenases (Nde1 and Nde2) and one NADH-
ubiquinone oxidoreductase, Ndi1 [192,193]. ETC-dependent ROS
production is possible only when the ETC is functional. The ROS
level increases in response to ETC perturbation but substantially
decreases when there is no ﬂow of electrons through the ETC, e.g.,
in rho0 mutants [12]. Interestingly, under certain circumstances,
rho0 cells have a better chance of survival than rhoþ cells. rho0 cells
are 100-fold more resistant to the lethal effects of ROS generated by
bleomycin and phleomycin D than are respiratory-competent cells.
Moreover, when the same exogenous oxidative stress was applied
to rhoþ cells, the majority of survivors lost mitochondrial function.
Furthermore, the lack of DNA repair genes, such as RAD52 or BLM5,
in diploid strains, which is highly mutagenic and causes hypersen-
sitivity to free radicals in respiratory-competent cells, does not
affect the resistance of the surviving cells that lack mitochondrial
function. Losses in mitochondrial function were dependent only on
the dose of the applied chemical. Thus, the inactivation of mito-
chondrial function may protect cells against the lethal effects of
oxygen free radicals [194].
Nevertheless, in wild-type cells, an efﬁcient ETC is required not only
for proﬁcient energy delivery but also for the appropriate stress
response and nuclear genome preservation. The latter function is
connected with the presence of the membrane potential rather than
with ROS production. As previously stated, ROS provoke primarily
point mutations and cause problems when the cell has a defective
capacity to defend against DNA damage. However, the loss of the
electrochemical potential ΔΨ destroys nearly all mitochondrial func-
tions, mitochondrial transport, prosthetic group production, and mito-
chondrial biosynthetic processes, and this condition is frequently linked
to an elevated rate of rearrangements in nuclear DNA [11,195,196].
Impaired iron–sulfur cluster production leads to nuclear genome
rearrangements
A series of elegant experiments showed that the cellular crisis
observed in rho0 cells manifesting as progressively slower growth, cell
cycle arrest, and nuclear genome instability correlates with a defect in
iron–sulfur cluster biogenesis due to a reduction in the ΔΨ [11].
Several pieces of evidence conﬁrmed this conclusion. First, the crisis
observed upon mtDNA loss was not a consequence of respiratory
deﬁciency. The deletions of three independent nuclear genes required
for respiration at various steps of the ETC, namely CAT5 (monoox-
ygenase required for ubiquinone biosynthesis), RIP1 (ubiquinol-cyto-
chrome c reductase), and COX4 (subunit IV of cytochrome c oxidase),
had no effect on the growth rate, regardless of the mtDNA content in
the analyzed cells. Second, cells carrying the ATP1-111 allele, which
encodes a hyperactive F1 ATP synthase and generates a higherΔΨ in
rho0 than in wild-type rho0 cells, did not present any detectable crisis.
Third, downregulation of the nonmitochondrial, cytosolic Nar1 pro-
tein, which is required for cytosolic and nuclear Fe–S protein
maturation, was sufﬁcient to cause increased genomic instability in
cells with intact mitochondrial function. These results suggest an
essential role of mitochondria in the formation of ISCs, which are
catalytic and structural components of many cellular proteins,
including those involved in DNA replication and repair. Moreover,
the proteins involved in ISC biogenesis or in the assembly of various
Fe–S proteins are also required to maintain nuclear genome integrity.
Mutations in these genes cause a chromosome instability phenotype
that is severe for the CIA1 and DRE2 genes [197] and moderate for the
RLI1 gene [198]. The ISA2 and NBP35 genes were identiﬁed in
genomic screens as being responsible for the maintenance of the
diploid genome. In various assays, homozygous isa2/isa2 and hetero-
zygous NBP35/nbp35: kanMX4 strains manifest a mutator phenotype
[199]. Nbp35 is one of several Fe–S proteins (the others are Cfd1, Nfs1,
Isu1, Isu2, Ncs2, and Cia1) that are engaged in wobble tRNA
modiﬁcation [200,201]. Because modiﬁed nucleosides near the antic-
odon are important for the proper decoding of mRNA by the
ribosome, using the wrong tRNA during translation leads to proteo-
toxic stress. This proteotoxic stress may subsequently lead to genome
destabilization [169,202,203]. In Schizosaccharomyces pombe cells, the
loss of activity of the cytosolic thiouridylase complex Ctu1–Ctu2
responsible for the 2-thiolation of cytosolic tRNAs causes misreading
and frameshifting during translation and ultimately results in severe
genome instability [204].
The results obtained using Zim17-depleted strains shed more
light on the manner in which disturbing the Fe–S biosynthesis
machinery affects the cellular genome. Zim17 functions as a zinc-
ﬁnger motif heat shock protein and chaperone to maintain the
activity of other chaperones, such as the mtHsp70 homologs Ssc1
and Ssq1 [205]. Zim17 directly assists in the functional interaction
of chaperones with substrate proteins in a J-type cochaperone-
dependent manner [206]. However, cells lacking Zim17 have limited
respiration activity, mimic the metabolic response to iron starva-
tion, and suffer from a dramatic increase in nuclear genome
recombination [207]. Neither ROS nor deﬁcient DNA repair accounts
for the genome hyperrecombination phenotype observed in a
zim17Δ strain. The lack of the Zim17 protein leads to the following:
(1) ISC protein assembly perturbation and the improper assembly of
DNA polymerase complexes and (2) the nuclear accumulation of
preribosomal particles followed by G1 cell cycle arrest. Therefore,
the hyperrecombination phenotype of the zim17Δ strain is prob-
ably caused by a shortage of proteins needed for faithful DNA
replication. The cellular requirement of Zim17 depends on the
growth conditions. A zim17 conditional mutant growing on fermen-
table medium, even at a permissive temperature, displayed a
tendency to lose its respiratory competence, showed vast aggrega-
tions of the mitochondrial Ssq1 chaperone, and was accompanied
by a defect in Fe–S protein biogenesis. Under respiring conditions,
the mitochondrial Hsp70's Ssc1 and Ssq1 exhibited only a partial
aggregation in the same zim17 mutants [206].
Strains carrying a mutation in the MET18/MMS19 gene display a
variety of phenotypes, including methionine auxotrophy, sensitivity to
genotoxic stress, and the presence of extended telomeres. The role of
Met18 in preventing genome instability became more obvious when
this protein was found to function as part of the cytosolic iron–sulfur
protein assembly (CIA) targeting complex, in which it serves as an
adapter between early-acting CIA components and a subset of cellular
Fe–S proteins. As shown previously, Met18/Mms19 speciﬁcally coim-
munoprecipitated with two DNA helicases, Rad3 and Dna2, and
several other Fe–S proteins, including Met10, Rli1, and the DNA
glycosylase Ntg2. These results explain the involvement of Met18 in
methionine biosynthesis, telomere maintenance, and DNA replication
and repair [208]. A similar function is carried out by MMS19, an
Met18 ortholog in mice [209].
Although the list of ISC-containing proteins in S. cerevisiae is
incomplete (Table 2), functional annotations of some of the known
proteins directly implicate a role in nuclear genome maintenance.
The nuclear proteins that contain ISCs include the following: Pri2,
a primase involved in lagging-strand DNA synthesis and important
in DNA double-strand break repair [215]; the catalytic subunits of
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all three replicative DNA polymerases, α, δ, and ε, and the
specialized DNA polymerase ζ that is involved in postreplicative
repair in yeast [218]; the glycosylase Ntg2, which is involved in
base-excision repair [214]; and various helicases, including Rad3,
which is involved in nucleotide-excision repair (NER) [220,221],
and Dna2, which is required for Okazaki fragment processing and
recombinational DNA repair [87]. For all these proteins, iron–
sulfur clusters are critical to their molecular functions.
The family of Fe–S proteins includes also cytosolic and mitochon-
drial metabolic enzymes that are crucial for proper cell functioning
and proteins involved in the ETC (Sdh2, Rip1, Cir2), enzymes engaged
in the TCA cycle (Aco1), and proteins in various pathways of amino
acid (Lys4, Ilv3, Leu1, Met5, Glt1), heme (Hem15), biotin (Bio2), and
lipoic acid (Lip5) biosynthesis (Table 2). Unexpectedly, in addition to
their enzymatic function, Ilv3 and Aco1 were found to be involved in
the maintenance of the nuclear genome [199,223]. As mentioned in a
previous section, Aco1 is also essential for mitochondrial genome
maintenance for two reasons: (1) it can replace Abf2 in its mtDNA
packaging function and physically protect mtDNA [41] and (2) it
protects the cell against citrate accumulation and toxicity [44,224].
Two independent explanations of citrate accumulation toxicity exist
in the literature. First, Lin et al. [224] link citrate toxicity with the
ionized form of this metabolite based on their observation that the
effect of elevated cellular citrate was partially alleviated by the
addition of iron or by an increase in pH in the growth medium in
an aco1Δ strain. Second, Farooq et al. [44] believe that citrate toxicity
results from citrate/iron chelate formation resulting in oxidative
damage to mtDNA. The authors argue that iron homeostasis is a
highly complex process and that Lin et al. actually did not show that
exogenous iron addition increased the iron levels in the mitochondria.
The authors noted differences in strain backgrounds and growth
conditions between the two studies, which may have affected the
mtDNA loss associated with the aco1Δ mutation. Farooq et al.
showed that the RTG pathway is activated in aco1Δmutants, leading
to increased expression of the gene encoding citrate synthase. A high
level of citrate synthase leads to iron accumulation in the mitochon-
dria, where H2O2 is present because of Sod1 superoxide dismutase
activity. Subsequently, the accumulated iron reacts with H2O2 to
generate very active hydroxyl radicals that destabilize the mtDNA. The
fact that mutations in RTG genes, genes encoding citrate synthase,
mitochondrial iron transporters, or superoxide dismutase Sod1, all
prevented mtDNA loss in aco1Δ cells strongly supports the second
explanation [44]. Additional arguments in favor of this hypothesis
come from the works of Chen et al. [225]. These authors show that
although citrate is an iron chelator, the citrate–iron complexes are
toxic in the intracellular environment. The chelation of iron by citrate
was found to promote the autoxidation of Fe2þ (Fe2þ citrate-Fe3þ
citrate e). The autoxidation of Fe2þ results in the peroxidation of
lipids in test solutions and in isolated mitochondria. In an intracellular
reducing environment, citrate-dependent iron oxidation increases
and leads to iron citrate toxicity. However, the data presented above
do not necessarily exclude the previously proposed role of Aco1,
independent of its enzymatic activity, in mtDNA maintenance [41], as
mentioned under Mitochondrial nucleoid proteins in S. cerevisiae.
Abnormal dNTP pool size, altered bias, or changed cellular distribution
often leads to mutagenesis and/or chromosomal instability
dNTP biosynthesis proceeds partially in mitochondria. Mito-
chondria are involved in dNTP biosynthesis at various stages of this
biological process. For example, the de novo biosynthesis of
pyrimidines requires the mitochondrial Ura2 enzyme, the bifunc-
tional carbamoylphosphate synthetase/aspartate transcarbamylase,
which catalyzes the ﬁrst two steps in this process [226]. There are
two adenylate kinases required for purine metabolism: Adk2 is a
mitochondrial enzyme, and Adk1 is localized in both the
mitochondria and the cytoplasm [227]. In addition, mitochondria
provide a supply of precursors for purine and pyrimidine biosynth-
esis via the activity of multiple enzymes, including Shm1, a serine
hydroxymethyltransferase, and Idp1, an isocitrate dehydrogenase.
Under respiratory conditions, the mitochondrial ETC is the major
source of ADP phosphorylation. Finally, mitochondria contribute to
the formation of the ribonucleotide-diphosphate reductase complex
(RNR). The RNR is the enzyme responsible for the rate-limiting step
in dNTP synthesis and its activity is tightly regulated. RNR activity is
strongly dependent on mitochondria, which deliver three compo-
nents necessary for the assembly of the complex: (1) diferric-
tyrosyl radical cofactor [FeIII2 -Y], an atypical iron prosthetic group
for the enzyme; (2) a monothiol glutaredoxin heme protein com-
plex, Grx3–Grx4; and (3) the ISC assembly complex Dre2–Tah18
[222,228,229]. The electron donors required for RNR reduction
reactions, cytoplasmic thioredoxins (Trx1 and Trx2), are also heme
proteins [230]. Therefore, the role of mitochondria in cellular dNTP
production is crucial.
The size of the dNTP pools and their need to be tightly
regulated ensure optimized DNA metabolism. The dNTP pool
concentration oscillates during the cell cycle, reaching a maximum
during the G1/S transition to prepare cells for the next round of
DNA replication and contribute to cycle progression [231]. The
dNTP pools expand in response to genotoxic stress conditions and
stalling of the replication fork, facilitating the continuation of
replication through the DNA lesions [232–237]. However, an
elevated dNTP pool size has consequences. As shown for human
cells, elevated dNTP pools inhibit the proofreading activity of DNA
polymerases, enhance dNTP misincorporation, and often lead to an
increased mutation rate [238,239]. Unfortunately, abnormalities in
the dNTP pools can provoke point mutations and DNA breaks,
which can lead to gross DNA rearrangements in the cellular
genome [232,235,240–242]. Thus, maintaining proper dNTP levels
is essential for cellular viability and genome stability, particularly
during oxidative stress. Cells lacking the peroxiredoxin Tsa1, an
enzyme crucial for antioxidant cellular defense and signaling,
exhibit elevated levels of dNTPs, which appear to underlie the
genome instability in this mutant [243].
Mitochondria are involved in the dNTP supply to other cellular
compartments. The imbalance in cytosolic dNTP pools due to
mitochondrial dysfunction leads to chromosomal instability, as
was shown in yeast and human cells [172,244]. Sometimes, a
particular mutation may lead to an imbalance in the dNTP pools in
mitochondria. For example, yeast cells lacking the POS5 gene,
which encodes the mitochondrial NADH kinase, contain abnormal
dNTP pools that are doubled in size in mutant mitochondria
compared to wild-type mitochondria. This difference is responsi-
ble for the mutator phenotype of the pos5 strain; however, the lack
of antioxidant protection also contributes to elevated mitochon-
drial genome mutagenesis [245].
The results of experiments summarized below provide evidence
for an additional connection among mitochondria, nucleotides, and
genome stability. Because both dNTP synthesis and the ETC require
nucleotides as substrates, nucleotide transport to mitochondria is
crucial for the proper functioning of these processes. Moreover, one
nucleotide, GTP, is involved in iron homeostasis in the mitochon-
drial matrix. Absence of the yeast mitochondrial GTP/GDP carrier
protein Ggc1, in addition to causing decreased levels of matrix GTP
and increased levels of matrix GDP, manifests as high cellular iron
uptake and remarkable iron accumulation within the mitochondria.
The expression of the human nucleoside diphosphate kinase Nm23-
H4 in yeast ggc1 mutant cells increases the level of GTP at the
expense of ATP via γ-phosphate group translocation from ATP to
GDP, restoring normal iron regulation. Thus, the Ggc1-dependent
GTP/GDP levels in the mitochondrial matrix mediate iron metabo-
lism [246]. Beyond their role in respiration to exchange cytosolic
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Table 2
Fe–S proteins in yeast Saccharomyces cerevisiae and their function, localization, bound cluster types, and human orthologs, as well as diseases linked to their malfunction and
proteins involved in their assembly.
Fe–S protein Protein
name
Localization Molecular function Cluster type Human
ortholog
Human diseases associated with the gene
(number of associated diseases)
Fe–S proteins involved in electron transport
Succinate
dehydrogenase
Sdh2 Mitochondrial
inner
membrane
Succinate dehydrogenase
(ubiquinone) activity, SDH (complex
II)
[2Fe–2S] SDHB (94) e.g., cancers, tumors, sarcomas,
carcinomas, paraganglioma,
neuroblastoma, myeloma, leukemia,
hyperparathyroidism, atherosclerosis,
retinitis, asthma, pheochromocytoma,
Cowden syndrome, Huntington disease,
Parkinson disease, Alzheimer disease,
dementia, narcolepsy, hypertension,
ischemia, obesity, diabetes mellitus,
insulinoma, diabetic retinopathy,
myopathy, lipomatosis
Complex III Rip1 Mitochondrial
inner
membrane
Ubiquinol-cytochrome c reductase,
a Rieske Fe–S protein (complex III)
[2Fe–2S] UQCRF-
S1
(17) e.g., prostate and breast cancer,
leukemia, Huntington disease, Alzheimer
disease, renal cell carcinoma,
myelodysplastic syndromes, Parkinson
disease, liver disease
Ferredoxina Yah1b Mitochondrial
matrix
Maturation of Fe–S proteins,
biosynthesis of heme A, steroid
biosynthesisc
[2Fe–2S] Adreno-
doxin/
FDX
(18) e.g., lung cancer, rickets, muscular
atrophy
Electron transfer
ﬂavoprotein
dehydrogenase
Cir2 Mitochondrion Catabolism of amino acids and
choline, β-oxidation of fatty acids
[4Fe–4S] ETFDH (22) e.g., myeloma, cancers, mental
retardation, hypoglycemia, myopathy,
Reye syndrome, riboﬂavin deﬁciency,
multiple acyl-CoA dehydrogenase
deﬁciency, lipid storage disease, glutaric
acidemia II severe neonatal type
Fe–S proteins involved in metabolism
Aconitase Aco1 Mitochondrial
matrix
TCA cycle; component of the
mitochondrial nucleoid
[4Fe–4S] ACO1 (33) e.g., melanoma, asthma, Alzheimer
disease, ataxia, Parkinson disease,
cataract, intellectual disability,
hepatoblastoma, thalassemia,
hemochromatosis, anemia, restless legs
syndrome
Homoaconitase Lys4 Mitochondrial
matrix
Biosynthesis of lysine (aconitase-
like)
[4Fe–4S] —
Dihydroxy acid
dehydratase
Ilv3b Mitochondrial
matrix
Biosynthesis of branched-chain
amino acids
[4Fe–4S] —
Lipoate synthase Lip5 Mitochondrial
matrix
Biosynthesis of lipoic acid [2Fe–2S], [4Fe–4S] VTA1 (3) e.g., thyroiditis, tonsillitis
Biotin synthase Bio2 Mitochondrial
matrix
Biosynthesis of biotin [2Fe–2S], [4Fe–4S] —
Ferrochelatase Hem15b Mitochondrial
inner
membrane
Heme biosynthesis [2Fe–2S]c FECH (46) e.g., adenocarcinoma, prostate cancer,
neuronitis, myelomas, endotheliitis,
leukemia, hepatitis, thyroiditis,
myeloproliferative disorder, Alzheimer
disease, ataxia, arthritis, tonsillitis,
anemia, oligodendroglioma, porphyria,
keratoderma, Friedreich ataxia,
porokeratosis
Isopropylmalate
isomerase
Leu1 Cytoplasm Biosynthesis of leucine (aconitase-
like)
[4Fe–4S] —
Sulﬁte reductase Met5/
Ecm17
Cytoplasm Biosynthesis of methionine,
contains siroheme
[4Fe–4S] —
Glutamate
dehydrogenase
Glt1 Cytoplasm Biosynthesis of glutamate [4Fe–4S] —
Fe–S proteins involved in genome stability
Primase Pri2b Nucleus Subunit of DNA primase, synthesis
of RNA primer during replication,
involved in DSB repair
[4Fe–4S] PRIM2 (1) cerebritis
DNA polymerase α Pol1b Nucleus Catalytic subunit of the DNA
polymerase α-primase complex,
initiation of DNA replication
[4Fe–4S] POLA1 (22) e.g., retinoblastoma, age-related
macular degeneration, acquired
immunodeﬁciency syndrome,
encephalitis, ophthalmoplegia, N
syndrome, xeroderma pigmentosum,
Netherton syndrome, Alpers syndrome
DNA polymerase δ Pol3b Nucleus DNA replication polymerase with
proofreading exonuclease activity,
lagging-strand synthesis, DNA
repair
[4Fe–4S] POLD1 (42) e.g., labyrinthitis, melanoma, various
cancers, myeloma, leukemia, meningioma,
obesity, tonsillitis, adenoma, multiple
sclerosis, acquired immunodeﬁciency
syndrome, lipodystrophy, encephalitis,
leukodystrophy, ophthalmoplegia,
mutism, Werner syndrome, xeroderma
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Table 2 (continued )
Fe–S protein Protein
name
Localization Molecular function Cluster type Human
ortholog
Human diseases associated with the gene
(number of associated diseases)
pigmentosum, Cockayne syndrome,
Alpers syndrome, progeroid features
DNA polymerase ε Pol2b Nucleus DNA replication polymerase with
proofreading exonuclease activity,
leading-strand synthesis, DNA
repair
[4Fe–4S] POLE (34) e.g., leukemia, various cancers,
retinitis, myeloma, blindness, colorectal
cancer, neuroblastoma, narcolepsy,
adenoma, multiple sclerosis, acquired
immunodeﬁciency syndrome,
encephalitis, xeroderma pigmentosum,
Alpers syndrome, Fils syndrome
DNA polymerase ζ Rev3 Nucleus Catalytic subunit of DNA polymerase
ζ, involved in TLS during
postreplication repair
[4Fe–4S] POLZ/
REV3L
(27) e.g., leukemia, adenocarcinoma,
various cancers, retinitis, inﬂammatory
bowel disease, osteosarcoma, acquired
immunodeﬁciency syndrome,
encephalitis, Fanconi anemia,
ophthalmoplegia, xeroderma
pigmentosum
DNA helicase Rad3b,d Nucleus 50–30 DNA helicase; involved in NER
and transcription
[3Fe–4S], [4Fe–4S] XPD (3) xeroderma pigmentosum, Cockayne
syndrome, trichothiodystrophy
DNA helicase Dna2b Nucleus and
mitochondrion
ATP-dependent DNA helicase; 50-
ﬂap endonucleases; Okazaki
fragment processing; DNA repair
[3Fe–4S], [4Fe–4S] DNA2 (3) myopathy, Werner syndrome, malaria
DNA glycosylase Ntg2 Nucleus DNA N-glycosylase and AP lyase;
BER
[4Fe–4S] NTHL1 (22) e.g., leukemia, colorectal cancer,
adenoma, multiple sclerosis, tuberous
sclerosis, cholangitis, mitochondrial
disorders
Fe–S proteins involved in regulation and assembly
RNase L inhibitor Rli1b Cytoplasm and
nucleus
Biogenesis of ribosomes, rRNA
processing, translation initiation
and termination, assembly of RNA
complexes, ABC family ATPase
2 [4Fe–4S] ABCE1 (15) e.g., adenocarcinoma, several cancers,
neuropathy
Glutaredoxin 2 Grx2 Mitochondrion Glutathione-dependent
oxidoreductase
[2Fe–2S] GLRX2 (14) e.g., melanoma, cervicitis, lung
cancer, ischemia, Parkinson disease
Histone
acetyltransferase
Elp3 Nucleus Histone acetyltransferase subunit of
the elongator complex, cluster binds
S-adenosylmethionine
[4Fe–4S] ELP3 (3) melanoma, neuronitis, malaria
ISC assembly Dre2b Cytoplasm and
mitochondrial
intermembrane
space
Electron carrier activity, ISC
assembly; cytokine-induced
apoptosis inhibitor 1
[2Fe–2S], [4Fe–4S] Ciapin
1/
anamor-
sin
(15) e.g., carcinoma, leukemia, B cell
lymphomas, cancers
NADPH-dependent
diﬂavin reductase
Tah18b Mitochondrion Component of an early step in the
CIA, transfers electrons from NADPH
to the ISC of Dre2p; plays a prodeath
role under oxidative stress; Tah18p-
dependent NO synthesis confers
high-temperature stress tolerance
NDOR1 (12) e.g., melanoma, teratoma, leukemia
CIA targeting complex Met18/
Mms19
Cytoplasm Component of a late step of Fe–S
CIA; complex with Cia1p and Cia2p
that directs ISC incorporation into a
subset of proteins involved in
methionine biosynthesis, DNA
replication and repair, transcription,
and telomere maintenance
MMS19 (7) e.g., ovarian cancer, pancreatic cancer,
Alzheimer disease, multiple sclerosis
CIA targeting complex Cia1b Cytoplasm and
nucleus
Component of a late step of CIA;
complex with Cia2 and Met18
CIAO1 (3) e.g., sarcomas, Wilms tumor
CIA targeting complex Cia2b Cytoplasm and
nucleus
Component of a late step of CIA;
complex with Cia1 and Met18
FAM96B (2) e.g., endotheliitis, malaria
Fe–S proteins involved in Fe–S protein biogenesis
Ferredoxina Yah1b Mitochondrial
matrix
Maturation of mitochondrial Fe–S
proteins, heme A biosynthesis,
steroid biosynthesisc
[2Fe–2S] Adreno-
doxin/
FDX
(18) e.g., lung cancer, rickets, muscular
atrophy
P-loop ATPase;
cysteine desulfurase
Nbp35b Cytoplasm and
nucleus
Maturation of cytosolic/nuclear Fe–S
proteins, complex with Cfd1; ATPase
[4Fe–4S] NFS1/
IscS
(7) e.g., hyperalgesia, liver failure,
cerebritis, ataxia, anemia
P-loop ATPase Cfd1b Cytoplasm Maturation of cytosolic Fe–S
proteins, complex with Nbp35 and
Nar1; ATPase; tRNA wobble uridine
modiﬁcation
[4Fe–4S] NUBP2 (7) e.g., endometriosis, ovarian neoplasms,
various cancers, syndactyly
Iron-only
hydrogenase
Nar1b Cytoplasm and
nucleus
Maturation of cytosolic/nuclear Fe–S
proteins, binds to Nbp35 and Cia1
Two clusters of
complex type
NARFL (6) e.g., glaucoma, breast cancer, pertussis;
genetic knockout causes embryonic
lethality
Components involved in Fe–S-cluster biosynthesis
Sulfur donor Nfs1b Mitochondrion
and nucleus
Cysteine desulfurase; cellular iron
ion homeostasis, ISC assembly, tRNA
thio-modiﬁcation, tRNA wobble
uridine modiﬁcation
NFS1 (7) e.g., ataxia, anemia, cerebritis
Isu1 [2Fe–2S] ISCU
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–104 89
Table 2 (continued )
Fe–S protein Protein
name
Localization Molecular function Cluster type Human
ortholog
Human diseases associated with the gene
(number of associated diseases)
Sulfur acceptor and
scaffold
Mitochondrial
matrix
Binding of ferric iron and
intermediate ISC, cellular iron ion
homeostasis, ISC assembly, tRNA
wobble uridine modiﬁcation;
interacts with frataxin
(18) e.g., myopathy, glioblastoma
multiforme, several cancers, sideroblastic
anemia, Friedreich ataxia, siderosis
ISC biogenesis Isd11b Mitochondrial
matrix
ISC biogenesis desulfurase-
interacting protein of 11kDa,
stabilizes Nfs1
LYRM4 (9) e.g., inﬂammatory bowel disease,
Crohn disease, spondylitis, schizophrenia,
ataxia
Sulfur acceptor and
scaffold
Isu2 Mitochondrial
matrix
Binding of ferric iron and
intermediate ISC
[2Fe–2S] ISCU (18) e.g., myopathy, glioblastoma
multiforme, several cancers, sideroblastic
anemia, Friedreich ataxia, siderosis
Scaffold Nfu1 Mitochondrial
matrix
ISC assembly, maturation of lipoate
synthase, and SDH
[4Fe–4S] HIRIP5/
NFU1
(14) e.g., multiple mitochondrial
dysfunctions syndrome type 1, myeloma
Scaffold Isa1 Mitochondrial
matrix
Required for maturation of
mitochondrial [4Fe–4S] proteins,
complex with Isa2, Isa1 deletion
causes loss of mtDNA and
respiratory deﬁciency
ISCA1 (3) choroiditis, malaria; may represent an
autoantigen in Sjogren syndrome
Scaffold Isa2 Mitochondrial
matrix
Required for maturation of
mitochondrial [4Fe–4S] proteins,
complex with Isa1
ISCA2 (3) hemophilia, malaria, tuberculosis
ISC biogenesis Iba57 Mitochondrial
matrix
Isa-interacting protein, biogenesis of
[4Fe–4S] clusters
IBA57 (2) multiple mitochondrial dysfunctions
syndrome 3, tooth resorption
Ferredoxina Yah1b Mitochondrial
matrix
Reduction of sulfur and iron or
intermediate of ISC formation,
electron transport
[2Fe–2S] Adreno-
doxin/
FDX
(18) e.g., lung cancer, rickets, muscular
atrophy
Ferredoxin reductase Yfh1b,d Mitochondrial
matrix
NAD(P)H-dependent reduction of
Yah1, iron chaperone; oxidizes and
stores iron; interacts with Isu1p to
promote ISC assembly
Fra-
taxin/
FXN
(41) e.g., Friedreich ataxia, ataxia, anemia,
adenocarcinoma, cancers, myeloma,
Huntington disease, neuropathy,
myocardial infarction, diabetes mellitus,
chorea mitochondrial disorders
Ferredoxin reductase Arh1b Mitochondrial
inner
membrane
NAD(P)H-dependent reduction of
Yah1; required for formation of
cellular iron–sulfur proteins and
involved in heme A biosynthesis
Adreno-
doxin
reduc-
tase/
FDXR
(17) e.g., colorectal cancer, muscular
atrophy, prostate cancer
Chaperone Ssc1b Mitochondrial
matrix
Hsp70/DnaK-type molecular
chaperone, required for assembly of
ISC transfer
HSPA9/
GRP75
(40) e.g., carcinomas, cancers, leukemia,
neuroblastoma, ataxia, Alzheimer disease,
type 1 diabetes, Parkinson disease,
myotonic dystrophy type 2, Down
syndrome
Chaperone Ssq1 Mitochondrial
matrix
Hsp70/DnaK-type molecular
chaperone, required for assembly of
ISC into proteins at a step after
cluster synthesis and for maturation
of Yfh1p, ATP hydrolyzing
component
HSPA9/
GRP75
(40) e.g., carcinomas, cancers, leukemia,
neuroblastoma, ataxia, Alzheimer disease,
type 1 diabetes, Parkinson disease,
myotonic dystrophy type 2, Down
syndrome
Cochaperone Jac1b Mitochondrial
matrix
Accessory chaperone of Hsp40/DnaJ
type, ATP hydrolyzing component
[4Fe–4S]c HSCB (12) e.g., chromosome aberrations,
adenocarcinoma, anemia, ataxia
Cochaperone Mge1b Mitochondrial
matrix
Mitochondrial GrpE, a nucleotide
release factor for Ssc1 in protein
translocation and folding;
cochaperone for Ssq1 in folding of
ISC proteins
GRPEL1 (3) various neoplasms, pneumonia
malaria
Chaperone Zim17b,d Mitochondrial
matrix
Zinc-ﬁnger HSP required for
maintenance of Ssq1 and Ssc1
proteins, essential for protein
import into mitochondria
ISC transporter Atm1b Mitochondrial
inner
membrane
ABC transporter, export ISC to the
cytoplasm, transport of hemec
ABCB7 (82) e.g., cancers, myelomas, carcinomas,
ataxia, anemia, thrombocytopenia,
hypercholesterolemia, liver disease,
blindness, Pearson syndrome, Addison
disease, substance abuse
ISC assembly Grx5 Mitochondrial
matrix
Monothiol glutaredoxin 5,
hydroperoxide and superoxide-
radical responsive glutathione-
dependent oxidoreductase
[2Fe–2S] GLRX5 (18) e.g., sideroblastic pyridoxine-
refractory autosomal recessive anemia
Aim1 ? Glutaredoxin-interacting protein,
maturation of lipoate synthase and
SDH, null mutant displays elevated
frequency of mtDNA loss
BOLA3 (8) e.g., multiple mitochondrial
dysfunctions syndrome type 1 and 2,
myeloma
Fe2þ transporter Mrs3 Mitochondrial
inner
membrane
Mitochondrial membrane iron
transporter active under low-iron
conditions, RNA splicing
SLC25-
A37/
mitofer-
rin
(9) e.g., anemia, neoplasms, arthritis
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ADP for mitochondrial ATP, the other two nucleotide carriers, ADP/
ATP and ATP-Mg/Pi, have a second function to import cytosolic ATP
into mitochondria and generate the ΔΨ. This alternative to the ETC
source of the mitochondrial membrane potential is essential for
proper functioning of the mitochondrial protein import and assembly
systems [195]. Other evidence suggests that the deletion of RIM2, the
gene encoding the mitochondrial pyrimidine nucleotide transporter,
impairs pyrimidine transport and causes defects in iron homeostasis,
heme synthesis, and ISC synthesis. Rupturing the mitochondrial
membrane to allow the free inﬂux of iron does not restore efﬁcient
heme synthesis in the absence of the Rim2 protein. These results
indicate that Rim2 is a pyrimidine exchanger with an additional
unique function in promoting mitochondrial iron utilization [247].
Moreover, Rim2 was found to act as a multicopy suppressor of pif1.
The Pif1 protein is a DNA helicase engaged in the replication,
recombination, and repair of mtDNA, but it also acts as a catalytic
inhibitor of telomerase during telomere addition and DSB repair in
the nucleus. In addition to telomeres, rDNA and Okazaki fragments
are also Pif1 substrates. Thus, the lack of Rim2 affects both mito-
chondrial and nuclear genome maintenance [248,249].
Because all mitochondrial nucleotide carriers mentioned above
are able to transfer their deoxy derivatives, an alternative explana-
tion for the importance of maintaining the cellular level of nucleo-
tide pools and their particular bias can be proposed while
considering the following: (1) the mitochondrial membrane poten-
tial is necessary to produce ISC and heme prosthetic groups; (2) ISCs
are the true sensors of the cellular iron level, and their abundance
regulates the transcription of iron-responsive genes; (3) ISCs sub-
sequently regulate iron homeostasis; and (4) homeostasis protects
cells against oxidative stress and metal toxicity. The current
assumptions state that the proper level and bias of dNTP pools
determine the start of replication, inﬂuence DNA synthesis ﬁdelity,
and enable the bypass of DNA lesions to rescue the cell from
replication block and cell cycle arrest; therefore, these steps con-
tribute to genome stability. However, the abundance of dNTP pools,
their cellular distribution, and their dNTP/dNDP/dNMP ratios con-
tribute to theΔΨ, which inﬂuences a variety of cellular functions, e.
g., cellular transport and ISC synthesis. The ISC level determines iron
homeostasis and adequate defense against oxidative stress. Because
a subset of DNA polymerases and helicases are also Fe–S proteins,
the ISC level governs the activities of these enzymes. Therefore,
properly balanced dNTPs counteract genome instability by main-
taining ΔΨ. This additional role of dNTPs in the cell is particularly
important in rho0 cells, in which the ETC is dysfunctional; thus, ISC
synthesis in these cells relies on alternative ΔΨ sources.
Metal homeostasis disruption impairs prosthetic group creation to
inﬂuence genome stability
Mitochondria are the major site of cellular iron utilization for
the synthesis of essential cofactors, such as iron–sulfur clusters
and heme. We previously described how ISC synthesis affects
genome stability. Heme synthesis is also relevant to this process
because a group of proteins possessing this prosthetic group can
affect the maintenance of the intact genome.
The heme-binding proteins (listed in Table 3) include the following:
proteins important for ETC functioning, e.g., cytochrome c (Cyc1), the
Cyt1 subunit of cytochrome bc1 complex subunit (complex III), the
Cox1 and Cox2 subunits of cytochrome c oxidase (complex IV),
cytochrome b2 (Cyb2, L-lactate cytochrome c oxidoreductase), and the
cytochrome c isoform 2 (Cyc7). The inﬂuence of these proteins on
genome maintenance was discussed earlier. However, heme-binding
proteins are involved in the response to oxidative stress, e.g., mito-
chondrial cytochrome c peroxidase Ccp1 [250] and nitric oxide
reductase Yhb1 [251], which serve as oxidative stress signal transdu-
cers. The cellular abundance of the latter protein is also enriched in
response to DNA replication stress [252]. The heme-binding proteins
play a crucial role in the antioxidant defense system. Catalase A (Cta1)
and catalase T (Ctt1), the enzymes that decompose H2O2 into O2 and
H2O molecules, are hemoproteins [253]. The activities of catalases
signiﬁcantly reduce the potential ROS-dependent damage in the cell,
including that of oxidative DNA lesions, to protect the genome.
Other known proteins possessing a heme prosthetic group are
involved in various biosynthetic pathways, such as lipid biosynth-
esis (Cyb5), ergosterol biosynthesis (Erg11, Erg5), fatty acid synth-
esis (Ole1), de novo biosynthesis of NAD (Bna2), synthesis of N,N-
bisformyl dityrosine (Dit2, which is required for spore wall
maturation), and amino acid biosynthesis (Met5). Other heme
proteins are involved in various metabolic pathways: Sdh4, which
is a membrane anchor subunit of succinate dehydrogenase; its
homolog Shh4, which couples the TCA cycle with the ETC; and
Scs7, which is a sphingolipid α-hydroxylase that functions in the
α-hydroxylation of sphingolipid-associated very long chain fatty
acids. For some heme-containing proteins, direct evidence exists
for their involvement in genome integrity. Strains lacking the
damage response protein Dap1, which is involved in the regulation
of cytochrome P450, exhibit sensitivity to MMS, telomere elonga-
tion, the loss of mitochondrial function, and partial arrest in sterol
synthesis. Moreover, after MMS treatment, dap1 mutants are
arrested as unbudded cells, suggesting that Dap1 is necessary for
cell cycle progression after alkylation damage [254]. Another
example is the Irc21 protein, which is involved in the resistance
to carboplatin and cisplatin, compounds that cause DNA cross-
linking, increase the number of spontaneous Rad52p foci [255],
and ultimately trigger apoptosis [256].
Mitochondria are the dedicated location for the maturation of
various metalloproteins that bind Mn2þ or Cu2þ ions, including
antioxidant defense enzymes. The superoxide dismutase Sod2,
which uses manganese as a cofactor, can misincorporate iron
when cells are starved for manganese or when the mitochondrial
iron homeostasis is disrupted by grx5, ssq1, or mtm1 mutations.
This iron misincorporation leads to Sod2 inactivation and occurs
Table 2 (continued )
Fe–S protein Protein
name
Localization Molecular function Cluster type Human
ortholog
Human diseases associated with the gene
(number of associated diseases)
Fe2þ transporter Mrs4 Mitochondrial
inner
membrane
Mitochondrial membrane iron
transporter active under low-iron
conditions, overproduced during
DNA damage, RNA splicing
SLC25-
A37/
mitofer-
rin
(9) e.g., anemia, neoplasms, arthritis
All information listed is available in [112–115,210–213], and the reader is referred to these sources and the references therein for further details. Additional data have been
published in [7,87,214–222].?, function/localization unclear or not yet analyzed.
a Ferredoxin is involved in heme and ISC biosynthesis and in Fe–S protein biogenesis.
b Essential for viability.
c Involves human cells.
d Viability depends on the genetic background.
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Table 3
The heme proteins in yeast Saccharomyces cerevisiae and their function, localization, bound heme types, and human orthologs, as well as diseases linked to their malfunction
and proteins involved in their assembly.
Heme protein Protein
name
Localization Molecular function Heme type Human ortholog Human diseases associated with
the gene (number of associated
diseases)
Heme proteins involved in ETC
Succinate
dehydrogenase
Sdh4 Mitochondrial
respiratory chain
complex II
Membrane anchor subunit of succinate
dehydrogenase that couples the TCA
cycle with ETC
Heme — —
Succinate
dehydrogenase
Shh4a Mitochondrial inner
membrane
Putative alternate subunit of succinate
dehydrogenase; Sdh4 homolog
Heme SDHD (43) e.g., paraganglioma,
pheochromocytoma,
neuroﬁbromatosis, mitochondrial
complex II deﬁciency
Electron carrier Cobb Mitochondrial
respiratory chain
complex III
Cytochrome b; subunit of the
ubiquinol-cytochrome c reductase
2 heme B MTCYB (5) e.g., Leber hereditary optic
neuropathy, encephalomyopathy,
mitochondrial complex III
deﬁciency
Electron carrier Cyt1a Mitochondrial
respiratory chain
complex III
Cytochrome c1; component of the
mitochondrial respiratory chain;
subunit of the mitochondrial
ubiquinol-cytochrome c reductase
Heme CYC1 (4) e.g., hyperglycemia,
mitochondrial complex III
deﬁciency
Electron carrier Cyc1a Mitochondrial
intermembrane space
Cytochrome c, isoform 1 (iso-1-
cytochrome c)
Heme Insulin-responsive hyperglycemia
Electron carrier Cyc7 Mitochondrial
intermembrane space
Cytochrome c isoform 2, expressed
under hypoxic conditions (iso-2-
cytochrome c)
Heme —
Cytochrome
c oxidase
Cox1b Mitochondrial
respiratory chain
complex IV
Subunit I of cytochrome c oxidase
(complex IV); complex IV is the
terminal member of the mitochondrial
inner membrane ETC
Heme A COX1 (5) e.g., prostaglandin-
endoperoxide synthase deﬁciency,
cystic ﬁbrosis
Cytochrome
c oxidase
Cox2b Mitochondrial
respiratory chain
complex IV
Subunit II of cytochrome c oxidase
(complex IV)
Heme COX2 (34) e.g., breast cancer, colorectal
cancer, cystic ﬁbrosis,
hypertension, adenoma
Cytochrome
c oxidase
Cox3b Mitochondrial
respiratory chain
complex IV
Subunit III of cytochrome c oxidase
(complex IV)
Heme COX3 —
Heme proteins involved in stress response
Catalase A Cta1a Mitochondrial matrix,
peroxisomal matrix
Catalase A; breaks down hydrogen
peroxide in the peroxisomal matrix
formed by acyl-CoA oxidase (Pox1)
during fatty acid β-oxidation
Heme CAT (150) e.g., acatalasemia, pityriasis
versicolor, meningitis, encephalitis,
diabetes, asthma, Alzheimer
disease, systemic lupus
erythematosus, rheumatoid
arthritis, cancers
Catalase T Ctt1 Cytoplasm Cytosolic catalase T; participates in
protection from oxidative damage by
hydrogen peroxide
Heme — —
Thioredoxin Trx1 Cytoplasm, fungal-type
vacuole, mitochondrial
intermembrane space
Cytoplasmic thioredoxin isoenzyme;
part of thioredoxin system, which
protects cells against oxidative and
reductive stress; disulﬁde
oxidoreductase; Tsa1 cofactor; Trx2
paralog
Heme TXN (8) myocarditis, allergic
bronchopulmonary aspergillosis,
ocular hypertension,
trypanosomiasis, skin squamous
cell carcinoma
Thioredoxin Trx2a Cytoplasm, fungal-type
vacuole
Cytoplasmic thioredoxin isoenzyme;
Trx1 paralog
Heme TXN (8) myocarditis, allergic
bronchopulmonary aspergillosis,
ocular hypertension,
trypanosomiasis, skin squamous
cell carcinoma
Thioredoxin Trx3a Mitochondrion Mitochondrial thioredoxin;
oxidoreductase required to maintain
the redox homeostasis of the cell;
forms the mitochondrial thioredoxin
system with Trr2, redox state is
maintained by both Trr2 and Glr1
Heme — —
Oxidoreductase Grx1 Cytoplasm, nucleus Glutathione-dependent disulﬁde
oxidoreductase (glutathione
peroxidase, glutathione transferase);
Grx2 paralog
Heme — —
Oxidoreductase Grx2a Cytoplasm,
mitochondrion
Cytoplasmic glutaredoxin
(thioltransferase, glutathione-
dependent disulﬁde oxidoreductase);
involved in maintaining redox state of
target proteins; Grx1 paralog
Heme — —
Oxidoreductase Grx3 Cytoplasm, nucleus Glutathione-dependent
oxidoreductase; hydroperoxide and
superoxide-radical responsive;
monothiol glutaredoxin subfamily
member along with Grx4 and Grx5;
Grx4 paralog
Heme GLRX3 (1) lymphocytic choriomeningitis
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Table 3 (continued )
Heme protein Protein
name
Localization Molecular function Heme type Human ortholog Human diseases associated with
the gene (number of associated
diseases)
Oxidoreductase Grx4 Nucleus Glutathione-dependent
oxidoreductase; hydroperoxide and
superoxide-radical responsive; Grx3
paralog
Heme GLRX3 (1) lymphocytic choriomeningitis
Oxidoreductase Grx5 Mitochondrial matrix Glutathione-dependent
oxidoreductase; hydroperoxide and
superoxide-radical responsive;
involved in the synthesis/assembly of
ISC
Heme GLRX5 (4) e.g., sideroblastic anemia,
Pearson syndrome, spasticity–
ataxia–gait anomalies syndrome
Monothiol
glutaredoxin
Grx6 Integral component of
membrane, ER, fungal-
type vacuole, Golgi
apparatus
Monothiol glutaredoxin, more similar
in activity to dithiol than other
monothiol glutaredoxins; binds ISC;
Grx7 paralog
Heme — —
Monothiol
glutaredoxin
Grx7a Integral component of
membrane, fungal-type
vacuole, Golgi apparatus
Monothiol glutaredoxin, more similar
in activity to dithiol than other
monothiol glutaredoxins; Grx6 paralog
Heme — —
Dithiol
glutaredoxin
Grx8 Cytoplasm Glutaredoxin that employs a dithiol
mechanism of catalysis
Heme — —
Peroxidase Ccp1 Mitochondrial
intermembrane space
Mitochondrial cytochrome c
peroxidase; involved in response to
oxidative stress
Heme — —
Nitric oxide
reductase
Yhb1 Mitochondrial matrix,
cytoplasm, nucleus
Nitric oxide reductase;
ﬂavohemoglobin involved in NO
detoxiﬁcation; plays a role in the
oxidative and nitrosative stress
response
Heme — —
Oxidoreductase Cyb2 Mitochondrial
intermembrane space
Cytochrome b2; L-lactate cytochrome c
oxidoreductase
Heme — —
Stress response
protein
Dap1a Endosome, membrane Heme-binding protein; involved in
regulation of cytochrome P450 protein
Erg11; damage response protein;
mutations lead to defects in telomeres,
mitochondria, and sterol synthesis
Heme PGRMC1 (13) e.g., trigeminal neuralgia,
spondylolisthesis, parotitis,
tracheal stenosis, cancers,
carcinomas
Stress response
protein
Ynl234w Cytoplasm Heme protein involved in stress
response; involved in glucose signaling
or metabolism; regulated by Rgt1
Heme — —
Stress response
protein
Irc21 Cytoplasm Heme protein involved in drug
response (carboplatin and cisplatin);
shares similarity to a human
cytochrome oxidoreductase; null
mutant displays increased levels of
spontaneous Rad52 foci
Heme — —
Disulﬁde
oxidoreductase
Eug1 ER lumen Heme lyase disulﬁde oxidoreductase;
involved in protein folding; Pdi1
paralog
Heme — —
Disulﬁde
isomerase
Pdi1a,c ER lumen Protein disulﬁde isomerase; involved
in protein folding; Eug1 paralog
Heme P4HB (3) malaria, pseudoachondroplasia,
malignant glioma
Disulﬁde
isomerase
Mpd1a Fungal-type vacuole Protein disulﬁde isomerase, interacts
with and inhibits the chaperone
activity of Cne1
Heme — —
Disulﬁde
isomerase
Mpd2 ER Protein disulﬁde isomerase; involved
in protein folding
Heme — —
Heme proteins involved in metabolism
Cytochrome b5 Cyb5 ER membrane Cytochrome b5; involved in the sterol
and lipid biosynthesis pathways; acts
as an electron donor to support sterol
C5-6 desaturation; involved in sterol
and lipid biosynthesis
Heme CYB5B (1) Non-Hodgkin lymphoma
Sterol 14-
demethylase
Erg11c,d ER Lanosterol 14-α-demethylase from
cytochrome P450 family; catalyzes the
C-14 demethylation of lanosterol to
form 4,4″-dimethyl cholesta-8,14,24-
triene-3-β-ol; involved in ergosterol
biosynthesis
Heme CYP51A1 (2) Chagas disease, Antley-Bixler
syndrome
C-22 sterol
desaturase
Erg5a ER C-22 sterol desaturase; a cytochrome
P450 enzyme that catalyzes the
formation of the C-22(23) double bond
in the sterol side chain in ergosterol
biosynthesis; involved in ergosterol
biosynthesis
Heme — —
Stearoyl-CoA
9-desaturase
Ole1a Integral component
membrane, ER
Δ(9) fatty acid desaturase; required for
monounsaturated fatty acid synthesis
and for normal distribution of
mitochondria
Heme — —
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Table 3 (continued )
Heme protein Protein
name
Localization Molecular function Heme type Human ortholog Human diseases associated with
the gene (number of associated
diseases)
Fatty acid α-
hydroxylase
Scs7 Integral component
membrane, ER
Sphingolipid α-hydroxylase, which
functions in the α-hydroxylation of
sphingolipid-associated very long
chain fatty acids; the enzyme with
both cytochrome b5-like and
hydroxylase/desaturase domains
Heme FA2H (11) e.g., fatty acid hydroxylase-
associated neurodegeneration,
leukodystrophy, spastic
paraparesis, spastic paraplegia 35,
alcohol-related
neurodevelopmental disorder,
breast cancer, aceruloplasminemia
Indoleamine 2,3-
dioxygenase
Bna2 Cytoplasm Putative tryptophan 2,3-dioxygenase
or indoleamine 2,3-dioxygenase;
required for de novo biosynthesis of
NAD from tryptophan via kynurenine
Heme IDO2 (2) pancreatic cancer, pancreatitis
Sulﬁte reductase Met5a Cytoplasm, sulﬁte
reductase complex
(NADPH)
Sulﬁte reductase β subunit; involved in
amino acid biosynthesis
Heme MTHFR (283) e.g., homocystinuria and
homocysteinemia due to Mthfr
deﬁciency, neural tube defects,
vascular disease,
thromboembolism, schizophrenia,
acute leukemia
Heme oxygenase Hmx1a ER, nuclear outer
membrane
Heme oxygenase; involved in heme
degradation during iron starvation and
in the oxidative stress
Heme — —
Ferric-chelate
reductase
Fre1 Plasma membrane Ferric reductase and cupric reductase;
reduces siderophore-bound iron and
oxidized copper before uptake by
transporters
Heme CYBB/
GP91PHOX
(12) e.g., chronic granulomatous
disease, atypical mycobacteriosis,
familial X-linked 2, ehrlichiosis,
diastolic heart failure, low renin
hypertension
N-formyltyrosine
oxidase
Dit2a ? N-formyltyrosine oxidase; a
cytochrome P450 involved in synthesis
of N,N-bisformyl dityrosine required
for ascospore wall maturation
Heme — —
Disulﬁde
oxidoreductase
Prm4 Integral component of
membrane
Pheromone-regulated protein
proposed to be involved in mating
Heme — —
Transporters
ATP:ADP
antiporter
Aac1a Mitochondrial inner
membrane, cytoplasm
Mitochondrial inner membrane ADP/
ATP translocator; exchanges cytosolic
ADP for mitochondrially synthesized
ATP; heme transporter
Heme ANT1 (12) e.g., progressive external
ophthalmoplegia, hypertrophic
cardiomyopathy, diabetes mellitus,
myopathy
ATP:ADP
antiporter
Aac3 Mitochondrial inner
membrane
Mitochondrial inner membrane ADP/
ATP translocator; exchanges cytosolic
ADP for mitochondrially synthesized
ATP; heme transporter
Heme ANT1 (12) e.g., progressive external
ophthalmoplegia, hypertrophic
cardiomyopathy, diabetes mellitus,
myopathy
ATP:ADP
antiporter
Pet9c,d Mitochondrial inner
membrane
Major ADP/ATP carrier of the
mitochondrial inner membrane;
exchanges cytosolic ADP for
mitochondrially synthesized ATP; also
imports heme and ATP;
phosphorylated
Heme ANT1 (12) e.g., progressive external
ophthalmoplegia, hypertrophic
cardiomyopathy, diabetes mellitus,
myopathy
Transporter Ydl119C/
Hem25a
Mitochondrial inner
membrane
Putative mitochondrial transport
protein; mitochondrial transporter
family SLC25 member; induced in
response to the DNA-damaging agent
MMS
Heme SLC25A38 (3) e.g., sideroblastic anemia,
Pearson syndrome
Heme activator proteins
Transcription
factor
Hap1 Nucleus Zinc ﬁnger transcription factor;
involved in the complex regulation of
gene expression in response to levels
of heme and oxygen
Heme — —
Transcription
factor
Hap2 Nucleus Subunit of the heme-activated,
glucose-repressed Hap2/3/4/5 CCAAT-
binding complex, a transcriptional
activator and global regulator of
respiratory gene expression
Heme — —
Transcription
factor
Hap3 Nucleus, CCAAT-binding
factor complex
Subunit of the Hap2/3/4/5 CCAAT-
binding complex; complex is heme-
activated and glucose-repressed and a
transcriptional activator and global
regulator of respiratory gene
expression; contains sequences
contributing to both complex assembly
and DNA binding
Heme NFYB/ CBFB (12) e.g., myeloid leukemia,
cleidocranial dysplasia,
imperforate anus,
lymphoplasmacytic lymphoma
Transcription
factor
Hap4a Nucleus, CCAAT-binding
factor complex
Subunit of the Hap2/3/4/5 CCAAT-
binding complex; complex is heme-
activated and glucose-repressed and a
transcriptional activator and global
regulator of respiratory gene
expression; provides the principal
Heme — —
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Table 3 (continued )
Heme protein Protein
name
Localization Molecular function Heme type Human ortholog Human diseases associated with
the gene (number of associated
diseases)
activation function of the complex;
involved in diauxic shift
Transcription
factor
Hap5a Nucleus, CCAAT-binding
factor complex
Subunit of the Hap2/3/4/5 CCAAT-
binding complex; complex is heme-
activated and glucose-repressed and a
transcriptional activator and global
regulator of respiratory gene
expression; contains sequences
contributing to both complex assembly
and DNA binding
Heme — —
Components involved in heme assembly
Cytochrome
c–heme linkage
Cyc2 Extrinsic component of
mitochondrial inner
membrane
Mitochondrial peripheral inner
membrane oxidoreductase; contains a
FAD cofactor in a domain exposed in
the intermembrane space; probably
participates in ligation of heme to
acytochromes c and c1 (Cyc1 and Cyt1)
Heme — —
Cytochrome
c1–heme
linkage
Cyt2 Mitochondrial
intermembrane space
Cytochrome c1 heme lyase; involved in
maturation of cytochrome c1; links
heme covalently to apocytochrome c1
Heme HCCS (33) e.g., microphthalmia,
congenital diaphragmatic hernia,
hepatocellular carcinoma,
hepatitis, adenoma
Cytochrome
c–heme linkage
Cyc3 Mitochondrial
intermembrane space
Cytochrome c heme lyase
(holocytochrome c synthase); attaches
heme to apocytochrome c (Cyc1 or
Cyc7)
Heme — —
Cytochrome
c assembly
Cox11a Mitochondrial inner
membrane and
intermembrane space,
mitochondrial ribosome
Copper ion binding protein, required
for delivery of copper to Cox1
Heme COX11 (2) Leigh disease, breast cancer
susceptibility
Cytochrome
b assembly
Cor1 Mitochondrial
respiratory chain
complex III
Core subunit of the ubiquinol-
cytochrome c reductase complex (bc1
complex), which is a component of the
mitochondrial inner membrane ETC
Heme UQCRC1 —
Components involved in heme biosynthesis
First step Hem1c Mitochondrial matrix 5-Aminolevulinate synthase; catalyzes
the ﬁrst step in the heme biosynthetic
pathway
ALAS2 (20) e.g., X-linked sideroblastic
anemia, erythropoietic
protoporphyria, sickle cell disease,
microcytic anemia
Second step Hem2a,c Cytoplasm and nucleus Aminolevulinate dehydratase; a zinc-
dependent homo-octameric enzyme,
catalyzes the conversion of
5-aminolevulinate to porphobilinogen
ALAD (19) e.g., porphyria, lead poisoning,
tyrosinemia, uremia, hypochromic
anemia
Third step Hem3c Cytoplasm and nucleus Porphobilinogen deaminase; catalyzes
the conversion of 4-porphobilinogen to
hydroxymethylbilane
HMBS (16) e.g., porphyria, autosomal
dominant disease, lichen sclerosus,
ocular melanoma
Fourth step Hem4c ? Uroporphyrinogen III synthase;
catalyzes the conversion of
hydroxymethylbilane to
uroporphyrinogen III
UROS (32) e.g., porphyria, Dubin-Johnson
syndrome, hypertrichosis, arthritis,
prostate cancer, sarcoma
Fifth step Hem12c,d Cytoplasm and nucleus Uroporphyrinogen decarboxylase UROD (16) e.g., porphyria cutanea tarda,
siderosis, hepatitis, macrocytic
anemia
Sixth step Hem13c Cytoplasm Coproporphyrinogen III oxidase; an
oxygen-requiring enzyme
CPOX (16) e.g., porphyria, portal
hypertension, Kearns-Sayre
syndrome, Melas syndrome,
xeroderma pigmentosum group A,
ovarian epithelial cancer
Seventh step Hem14a Mitochondrial inner
membrane
Protoporphyrinogen oxidase PPOX (8) e.g., porphyria
Ferrochelatase Hem15c Mitochondrial inner
membrane
Ferrochelatase; catalyzes the insertion
of ferrous iron into protoporphyrin IX,
the eighth and ﬁnal step in the heme
biosynthetic pathway
Heme B FECH (17) e.g., porphyria, anemia,
hepatitis, porokeratosis
Protoheme IX
farnesyltransfe-
rase
Cox10a Integral component of
mitochondrial
membrane
Heme A:farnesyltransferase (heme O
synthase); catalyzes the ﬁrst step in
the conversion of protoheme to the
heme A prosthetic group required for
cytochrome c oxidase activity
Heme O COX10 (8) e.g., cytochrome c oxidase
deﬁciency, tubulopathy,
myopathyleukodystrophy, Leigh
syndrome, or infantile
hypertrophic cardiomyopathy
Heme acceptor Cox15 Mitochondrial inner
membrane
Protein required for the hydroxylation
of heme O to form heme A, which is an
essential prosthetic group for
cytochrome c oxidase
Heme A COX15 (15) e.g., Leigh disease,
hypertrophic cardiomyopathy,
mitochondrial DNA deletion
syndrome, cytochrome c oxidase
deﬁciency disease
Ferredoxin Yah1a,c Mitochondrial matrix Ferredoxin required for formation of
cellular iron–sulfur proteins and
involved in heme A biosynthesis
Heme A Adrenodoxin/
FDX
(18) e.g., lung cancer, rickets,
muscular atrophy
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–104 95
when the disruption of iron homeostasis is accompanied by an
increase in mitochondrial Isu proteins. Studies indicate that the
Isu1 and Isu2 proteins and the iron–sulfur pathway can donate
iron to Sod2 to cause enzyme deactivation [257], ROS elevation,
genotoxic stress, and an elevated mutation rate [258].
Changes in the abundance of proteins involved in mitochon-
drial ISC synthesis (e.g., Isu1, Yfh1, or Ssq1) modulate expression of
the iron-sensing transcription factor Yap5, which is responsible for
the elevated expression of the CCC1 gene, encoding a vacuolar iron
importer that responds to increased cytosolic iron. ISCs themselves
are sensors for both the high and the low iron transcriptional
responses. The deletion of cytosolic glutaredoxins or the loss of
activity of the cytosolic ISC assembly complex proteins did not
reduce the expression of Yap5 target genes [259]. Thus, mitochon-
drial ISC regulates transcription of the iron regulon and iron
uptake [260].
Detoxiﬁcation and the stress response capacity of mitochondria
prevent genotoxic stress and thereby help preserve the genome
Mitochondria have traditionally been recognized as the organelles
that produce the energy required to drive the molecular processes of
living cells. However, mitochondria have attracted more attention
recently as the most important cellular source of free radicals (the
primary free radicals O2ˉ and nitric oxide (NO), as well as the
termination products H2O2 and peroxynitrite (ONOOˉ)), as the main
target for free radical regulatory and toxic actions, and ﬁnally, as the
source of signaling molecules that regulate the cell cycle, proliferation,
and apoptosis [261]. To minimize the potentially harmful effects of ROS
in mitochondria, a network of antioxidants has evolved that consists of
the enzymes superoxide dismutase (Sod2, Sod1), glutathione perox-
idase (Gpx1, Gpx2), and peroxiredoxin with thioredoxin peroxidase
activity (Prx1), as well as the reductants NADH2, ubiquinol, and
reduced glutathione [262–267]. The effective cooperation of antiox-
idants in this network is crucial to guard mtDNA against ROS-driven
damage, to protect mitochondrial function, and, consequently, to
maintain the nuclear genome. However, not only mtDNA is threatened
when this antioxidant protection fails, but mitochondrion-generated
ROS can cause damage in nuclear DNA as well.
The generation of mitochondrial ROS can sometimes be provoked
by growth conditions. Ethanol accumulation during fermentation
contributes to toxicity in S. cerevisiae, impairing viability and fermen-
tative capacity. However, it has recently been shown that ISC mutants
show an impaired tolerance to ethanol. These mutants, the ssq1Δ,
isa1Δ, iba57Δ, and grx5Δ strains, display increased ROS generation,
mainly hydrogen peroxide and superoxide, when ethanol accumu-
lates to a toxic concentration during fermentation or upon ethanol
treatment. A decreased GSH/GSSG ratio, increased catalase activity,
and increased cytochrome c release from the mitochondria are
observed in the ISC mutants, suggesting that apoptosis is triggered
in response to ethanol stress [268].
The mitochondria are exposed to ROS produced locally, and
mitochondria are a primary target of cadmium-induced oxidative
stress. Prx1 is required to protect against mitochondrial oxidation and
Table 3 (continued )
Heme protein Protein
name
Localization Molecular function Heme type Human ortholog Human diseases associated with
the gene (number of associated
diseases)
Ferredoxin
reductase
Arh1c, Mitochondrial inner
membrane
Ferredoxin reductase, which performs
NAD(P)H-dependent reduction of
Yah1; required for formation of cellular
iron–sulfur proteins and involved in
heme A biosynthesis
Heme A Adrenodoxin
reductase/ FDXR
(17) e.g., colorectal cancer,
muscular atrophy, prostate cancer
SAM
uroporphyrino-
gen III
transmethylase
Met1c,d Intracellular S-adenosyl-L-methionine
uroporphyrinogen III transmethylase;
involved in the biosynthesis of
siroheme, a prosthetic group used by
sulﬁte reductase; required for sulfate
assimilation and methionine
biosynthesis; catalyzes also the ﬁrst
step in vitamin B12 biosynthesis
— —
Ferrochelatase Met8 ? Bifunctional dehydrogenase and
ferrochelatase; involved in the
biosynthesis of siroheme, a prosthetic
group used by sulﬁte reductase
Siroheme — —
All information listed is available in [112–115,210–213], and the reader is referred to these sources and the references therein for further details. Additional data have been
published in [250,251,253].?, function/localization unclear or not yet analyzed.
a Haploinsufﬁcient.
b Mitochondrially encoded.
c Essential for viability.
d Viability depends on the genetic background.
Fig. 1. Mitochondria–nucleus network of rhoþ and rho0 cells. Diagrams illustrating the link between mitochondria and the nucleus (A) when the mitochondrial compartment
harbors DNA or (B) when it has lost DNA. (A) In rhoþ cells, the TCA cycle is complete, and themitochondrial ETC functions properly. The latter process enables amino acid and dNTP
biosynthesis, ATP production, and generation of the membrane potential (ΔΨ), which is necessary for mitochondrial transport and the synthesis of prosthetic groups, such as heme
or ISC. Heme stimulates nuclear-encoded respiratory gene expression. The ISC level inﬂuences iron homeostasis and is a component of various essential protein complexes, e.g.,
ribosomes, DNA polymerases, and crucial enzymes fromvarious biosynthetic pathways. The ETC generates ROS, which play two opposite roles as cellular destructors or as signaling
molecules to trigger stress defense. (B) In rho0 cells, the ETC is dysfunctional, and subsequently, the TCA cycle is interrupted and amino acid and dNTP synthesis is impaired. A
starvation signal from the mitochondrion induces a retrograde response that launches mechanisms permitting the cell to survive, e.g., peroxisome proliferation (to supplement the
interrupted TCA), alternative amino acid synthesis pathways, and anaplerotic pathways. Iron homeostasis disturbances causing oxidative stress via the Fenton reaction and
impaired function of DNA polymerases and helicases, which are needed to repair the DNA lesions, are responsible for replication fork blocks and DNA rearrangement events in the
nuclear genome. Metallotoxicity and/or oxidative stress trigger the MDR response. A high intracellular level of ammonium, which can induce apoptosis, is lowered by the activity of
overproduced cognate carriers. The diagram presents a simpliﬁed model for clarity.
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–10496
A. Kaniak-Golik, A. Skoneczna / Free Radical Biology and Medicine 82 (2015) 73–104 97
plays a speciﬁc role in mediating cadmium tolerance [267]. The ﬁrst
step of catalysis performed by all peroxiredoxins results in the
oxidation of a conserved peroxidatic cysteine residue to sulfenic acid.
However, although most peroxiredoxins can be reactivated via the
mitochondrial thioredoxin system Trx3/Trr2, Prx1 is reactivated by
the glutathionylation of the catalytic cysteine residue and subsequent
reduction by the thioredoxin reductase Trr2 coupled with glutathione.
Because mitochondria play an active role in the biosynthesis of
many indispensable compounds and are invaluable in protecting the
cell against various stresses (oxidative, heavy metal, acidic, osmotic, or
heat shock stress [269]), a system that allows cells to survive mtDNA
destruction must exist. In fact, such a system does exist. rho0 cells
respond to the loss of genetic information encoded in mtDNAwith the
so-called retrograde response. This program of nuclear gene expression
comprises the expression of genes involved in various cellular pro-
cesses: (1) metabolism, e.g., CIT1, CIT2, ACO1, IDH1, and IDH2 to ensure
glutamate biosynthesis, genes encoding peroxisomal proteins (includ-
ing enzymes of fatty acid β-oxidation that would lead to increased
acetyl-CoA production), and genes involved in other anaplerotic
pathways [15]; (2) multidrug resistance (MDR); (3) sphingolipid
biosynthesis [196,270]; and, ﬁnally, (4) ammonium export [271]. The
mitochondrial retrograde signaling pathway is mediated by four
positive regulatory factors, Rtg1, Rtg2, Rtg3, and Grr1, and four negative
regulatory factors, Mks1, Lst8, and two 14-3-3 proteins (Bmh1 and
Bmh2). However, few retrograde-responsive genes exhibit RTG-
independent expression. Instead, their transcription is regulated by
Pdr3 (e.g., PDR5 encoding the ABC transporter, which is involved in
multidrug and cation resistance and cellular detoxiﬁcation) or Gcn4
and Ssy1 (e.g., ATO3 encoding the ammonium transmembrane trans-
porter). The role of sphingolipids and ammonium is important during
cellular exposure to various stresses. Recent work has implicated
sphingolipid synthesis and signaling as major mediators of iron toxicity
in yeast cells. Myriocin treatment or overexpression of the negative
regulator Orm2 blocks sphingolipid synthesis and leads to iron
resistance. High-iron conditions that cannot be resolved easily in rho0
cells, in which ISC synthesis is disturbed owing to ETC failure and
subsequent mitochondrial membrane potential loss, result in the
upregulation of sphingolipid synthesis. Increasing sphingolipid levels
by inactivating Orm2 exacerbates the sensitivity to iron. This toxicity is
mediated by sphingolipid signaling. Inactivation of the sphingolipid-
activated protein kinases (Pkh1 and Ypk1) and the transcription factor
Smp1 enhances the resistance to high-iron conditions [272]. The need
for ammonium export arises in rho0 cells for two reasons: (1) a defect
in ammonium assimilation in those cells leads to cellular ammonium
excess [271] and (2) excess ammonia stimulates programmed cell
death [273]. Thus, to survive, a cell must be able to eliminate ammonia.
These results agree with data obtained for mammalian cells, in which
ammonia provokes autophagy [274,275].
Apoptosis failure leads to genome instability
Mitochondria play a dual role in cell death. On one hand, various
mitochondrial dysfunctions can lead to apoptosis. Several ETC
dysfunctions mimic apoptosis via ROS production and cytochrome
c release. Zdralević et al. stated that programmed cell death and
retrograde signaling pathways are the two major intracellular path-
ways by which yeast cells respond to mitochondrial dysfunction
[269]. On the other hand, healthy mitochondria are necessary to
execute apoptosis when required by cellular systems. Apoptosis is
triggered when the harmful effects of cellular stress fail to permit
further healthy existence of the cell. When genomic DNA is
subjected to stress, causing severe damage leading to replication
block and subsequent mitotic arrest, the death of the affected cell is
not a simple repercussion but rather the mandatory event, and this
process is called mitotic catastrophe. The cells that escape execution
enter endless division problems that result in either senescence
culminating in cell death or continued aberrant divisions that result
in aneuploidization and often cell death because certain essential
genes are missing. Another outcome is mitotic slippage or cytokin-
esis failure, which results in polyploidization [276]. Both aneuploidy
and polyploidy are common phenotypes of various types of cancer
cells [277]. Vitale et al. stated that the avoidance of mitotic
catastrophe may represent one of the gateways to malignant
transformation [276]. Cellular death via mitotic catastrophe, regard-
less of whether it is enforced by apoptotic, autophagic, or necrotic
cell death pathways, has been detected in yeast cells exposed to
various endo- and exogenous stresses [278].
Yeast apoptosis shares most of the morphological and bio-
chemical hallmarks of mammalian apoptosis, with phosphatidyl-
serine externalization to the outer layer of the cytoplasmic
membrane, DNA fragmentation, chromatin condensation, the
involvement of speciﬁc proapoptotic proteins (e.g., Aif1 and Bxi1/
Ybh3), and the mitochondrion-dependent cell death pathway. This
ﬁnal pathway includes increased ROS production, loss of the ΔΨ,
the appearance of dysfunctional mitochondria, cytochrome c
release, and the opening of the outer mitochondrial membrane
voltage-dependent anion channel reviewed in [261, 279, 280]. We
mention a few of the mitochondrial proteins engaged in apoptosis.
The referenced papers represent the latest additions to a lengthy
apoptosis bibliography.
A recent report showed that Ndi1, a mitochondrial NADH:ubiqui-
none oxidoreductase that transfers electrons from NADH to ubiqui-
none in the respiratory chain and has a function similar (though not
identical) to that of complex I from higher eukaryotes, is transformed
into an apoptosis inducer after various apoptotic stimuli, including
H2O2, Mn, and acetic acid stresses. The proapoptotic function of Ndi1
relies on its proteolytic cleavage. Under stress conditions, the N-
terminal part of the protein that sequesters its toxicity is cleaved. This
cleavage activates a new function of this enzyme and permits its
escape from the mitochondria to execute its apoptotic function.
Therefore, cytochrome c is not the only protein that is released from
the mitochondria to promote apoptosis [281].
In addition, the Fe–S protein Tah18 is involved in apoptosis. The
TAH18 gene was previously identiﬁed as a synthetic lethal with a
conditional mutation in the catalytic subunit of DNA polymerase δ
[282]. Later, Tah18 was shown to be involved in the oxidative
stress response and to translocate to mitochondria after exposure
to stress [102]. Tah18 exhibits NADH and NADPH oxidoreductase
activity. The protein has a single molecular function and operates
on different substrates depending on changes in the environmen-
tal conditions. Therefore, under normal, nonstressful conditions,
Tah18 contributes to the early step in cytosolic Fe–S protein
assembly by transferring electrons from NADPH to the ISC of
Dre2 [228]. Although the Dre2–Tah18 complex is involved in iron
reduction, the release of bound iron from Dre2 might be affected
by its interaction with Tah18, resulting in an increased production
of hydroxyl radicals via the Fenton reaction. Under oxidative stress
conditions, Tah18 does not operate on Dre2 (the antiapoptotic
protein) but has deleterious effects on mitochondria and promotes
cell death [102]. Under high-temperature stress, Tah18 mediates
NO synthesis to confer heat shock tolerance to yeast cells
[283]. Notably, Dre2, the intramitochondrial partner of Tah18,
was directly implicated in genome maintenance because a strain
carrying a conditional mutation in the DRE2 gene displays a
mutator phenotype [197]. However, this mutator phenotype
might be linked to another Dre2–Tah18 complex function. The
Dre2–Tah18 complex plays a critical role in the biosynthesis
of the radical cofactor diferric-tyrosyl, an iron-containing group
that is necessary for RNR activity. The depletion of Dre2 affects the
transcription of RNR genes and the turnover of their mRNAs via
the following factors: (1) DNA damage checkpoint activation
depending on Mec1, Rad53, and Dun1 and (2) the Aft1/
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Aft2-controlled iron regulon. Therefore, cells with diminished
Dre2 levels show signiﬁcantly reduced dNTP levels [284].
Mitochondrial genome maintenance ensures functional mitochondria
and contributes to nuclear genome stability
The ﬁnding that preserving functional mitochondria inﬂuences
nuclear genome integrity has been thoroughly documented in
previous parts of this paper, and the mechanisms ensuring
mitochondrial genome stability were also extensively discussed
in a separate section (Fig. 1).
In the concluding remarks, we highlight one more example of
an extraordinary and unexpected connection between the mito-
chondrial and the nuclear genomes. DNA fragments that originate
from noncontiguous regions of the mitochondrial genome were
transferred during DSB repair to yeast nuclear chromosomes of
haploid mitotic cells. The subsequent detailed mitochondrial
genome analysis indicated that the yeast nuclear genome contains
several short sequences of mitochondrial origin with a size and
composition similar to those of the strands used to repair DSBs.
These sequences were found primarily in the noncoding regions of
the chromosomes. These data suggest that the mitochondrial
genome can act as a source of “curative” DNA in the nuclear
genome, and from an evolutionary perspective, this process could
explain the slow movement of mitochondrial genome fragments
into the nuclear DNA [285].
Conclusions
In our review, we summarized convincing data demonstrating
that mitochondria are an indispensable cellular compartment for
preserving the intact genome of the cell. Experimental data suggest a
variety of mitochondrial functions: (1) respiration and ATP delivery,
(2) biosynthesis of amino acids, (3) biosynthesis of nucleotides,
(4) prosthetic group production (ISC and heme), (5) metal home-
ostasis, (6) stress signaling, (7) stress defense, and (8) apoptosis
execution. These functions are involved in genome maintenance
processes, and their proper execution is crucial to prevent genome
instability (Fig. 1). However, the mitochondrion, with its ability to
produce ROS, is uniquely exposed to oxidative damage. We described
how many cellular resources are engaged in maintaining the proper
functioning of mitochondria, including their own genome preserva-
tion. This exciting entangled two-way network maintains cellular
homeostasis, links metabolism with genome stability, and ultimately
maintains the balance between life and death. We expect new data
will appear in the near future to identify other interesting connections
between mitochondria and the nuclear genome that link metabolism
with cell cycle progression or arrest and consequent cell proliferation
or apoptosis. These connections may eventually help elucidate the
association of mitochondrially generated ROS with neurodegenerative
diseases, such as Parkinson and Alzheimer diseases, as well as the
association of mitochondrial disorders with various cancers and other
pathologies. Finally, knowledge of mitochondrion–nucleus intercon-
nections will provide new insights into the aging process and assist in
determining how increasing environmental metal pollution interferes
with mitochondrial function and cellular homeostasis.s
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